#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Using concurrent EEG and fMRI to probe the state of the brain in schizophrenia Perceptional abnormalities in schizophrenia are associated with hallucinations and delusions, but also with negative symptoms and poor functional outcome.
1-1	0-5	Using	_
1-2	6-16	concurrent	_
1-3	17-20	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
1-4	21-24	and	_
1-5	25-29	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-6	30-32	to	_
1-7	33-38	probe	_
1-8	39-42	the	_
1-9	43-48	state	_
1-10	49-51	of	_
1-11	52-55	the	_
1-12	56-61	brain	_
1-13	62-64	in	_
1-14	65-78	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-15	79-91	Perceptional	_
1-16	92-105	abnormalities	_
1-17	106-108	in	_
1-18	109-122	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-19	123-126	are	_
1-20	127-137	associated	_
1-21	138-142	with	_
1-22	143-157	hallucinations	_
1-23	158-161	and	_
1-24	162-171	delusions	_
1-25	172-173	,	_
1-26	174-177	but	_
1-27	178-182	also	_
1-28	183-187	with	_
1-29	188-196	negative	_
1-30	197-205	symptoms	_
1-31	206-209	and	_
1-32	210-214	poor	_
1-33	215-225	functional	_
1-34	226-233	outcome	_
1-35	234-235	.	_

Text=Perception can be studied using EEG-derived event related potentials (ERPs).
2-1	236-246	Perception	_
2-2	247-250	can	_
2-3	251-253	be	_
2-4	254-261	studied	_
2-5	262-267	using	_
2-6	268-279	EEG-derived	_
2-7	280-285	event	_
2-8	286-293	related	_
2-9	294-304	potentials	_
2-10	305-306	(	_
2-11	307-311	ERPs	_
2-12	312-313	)	_
2-13	314-315	.	_

Text=Because of their excellent temporal resolution, ERPs have been used to ask when perception is affected by schizophrenia.
3-1	316-323	Because	_
3-2	324-326	of	_
3-3	327-332	their	_
3-4	333-342	excellent	_
3-5	343-351	temporal	_
3-6	352-362	resolution	_
3-7	363-364	,	_
3-8	365-369	ERPs	_
3-9	370-374	have	_
3-10	375-379	been	_
3-11	380-384	used	_
3-12	385-387	to	_
3-13	388-391	ask	_
3-14	392-396	when	_
3-15	397-407	perception	_
3-16	408-410	is	_
3-17	411-419	affected	_
3-18	420-422	by	_
3-19	423-436	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-20	437-438	.	_

Text=Because of its excellent spatial resolution, functional magnetic resonance imaging (fMRI) has been used to ask where in the brain these effects are seen.
4-1	439-446	Because	_
4-2	447-449	of	_
4-3	450-453	its	_
4-4	454-463	excellent	_
4-5	464-471	spatial	_
4-6	472-482	resolution	_
4-7	483-484	,	_
4-8	485-495	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-9	496-504	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-10	505-514	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-11	515-522	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-12	523-524	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-13	525-529	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-14	530-531	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-15	532-535	has	_
4-16	536-540	been	_
4-17	541-545	used	_
4-18	546-548	to	_
4-19	549-552	ask	_
4-20	553-558	where	_
4-21	559-561	in	_
4-22	562-565	the	_
4-23	566-571	brain	_
4-24	572-577	these	_
4-25	578-585	effects	_
4-26	586-589	are	_
4-27	590-594	seen	_
4-28	595-596	.	_

Text=We acquired EEG and fMRI data simultaneously to explore when and where auditory perception is affected by schizophrenia.
5-1	597-599	We	_
5-2	600-608	acquired	_
5-3	609-612	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
5-4	613-616	and	_
5-5	617-621	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
5-6	622-626	data	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
5-7	627-641	simultaneously	_
5-8	642-644	to	_
5-9	645-652	explore	_
5-10	653-657	when	_
5-11	658-661	and	_
5-12	662-667	where	_
5-13	668-676	auditory	_
5-14	677-687	perception	_
5-15	688-690	is	_
5-16	691-699	affected	_
5-17	700-702	by	_
5-18	703-716	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-19	717-718	.	_

Text=Thirty schizophrenia (SZ) patients and 23 healthy comparison subjects (HC) listened to 1000 Hz tones occurring about every second.
6-1	719-725	Thirty	_
6-2	726-739	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
6-3	740-741	(	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
6-4	742-744	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
6-5	745-746	)	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
6-6	747-755	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
6-7	756-759	and	_
6-8	760-762	23	_
6-9	763-770	healthy	http://maven.renci.org/NeuroBridge/neurobridge#Comparison
6-10	771-781	comparison	http://maven.renci.org/NeuroBridge/neurobridge#Comparison
6-11	782-790	subjects	http://maven.renci.org/NeuroBridge/neurobridge#Comparison
6-12	791-792	(	http://maven.renci.org/NeuroBridge/neurobridge#Comparison
6-13	793-795	HC	http://maven.renci.org/NeuroBridge/neurobridge#Comparison
6-14	796-797	)	http://maven.renci.org/NeuroBridge/neurobridge#Comparison
6-15	798-806	listened	_
6-16	807-809	to	_
6-17	810-814	1000	_
6-18	815-817	Hz	_
6-19	818-823	tones	_
6-20	824-833	occurring	_
6-21	834-839	about	_
6-22	840-845	every	_
6-23	846-852	second	_
6-24	853-854	.	_

Text=We used joint independent components analysis (jICA) to combine EEG-based event-related potential (ERP) and fMRI responses to tones.
7-1	855-857	We	_
7-2	858-862	used	_
7-3	863-868	joint	_
7-4	869-880	independent	_
7-5	881-891	components	_
7-6	892-900	analysis	_
7-7	901-902	(	_
7-8	903-907	jICA	_
7-9	908-909	)	_
7-10	910-912	to	_
7-11	913-920	combine	_
7-12	921-930	EEG-based	_
7-13	931-944	event-related	_
7-14	945-954	potential	_
7-15	955-956	(	_
7-16	957-960	ERP	_
7-17	961-962	)	_
7-18	963-966	and	_
7-19	967-971	fMRI	_
7-20	972-981	responses	_
7-21	982-984	to	_
7-22	985-990	tones	_
7-23	991-992	.	_

Text=Five ERP-fMRI joint independent components (JIC) were extracted.
8-1	993-997	Five	_
8-2	998-1006	ERP-fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
8-3	1007-1012	joint	_
8-4	1013-1024	independent	_
8-5	1025-1035	components	_
8-6	1036-1037	(	_
8-7	1038-1041	JIC	_
8-8	1042-1043	)	_
8-9	1044-1048	were	_
8-10	1049-1058	extracted	_
8-11	1059-1060	.	_

Text=The “ N100 ” JIC had temporal weights during N100 (peaking at 100 ms post-tone onset) and fMRI spatial weights in superior and middle temporal gyri (STG/MTG); however, it did not differ between groups.
9-1	1061-1064	The	_
9-2	1065-1066	“	_
9-3	1067-1071	N100	_
9-4	1072-1073	”	_
9-5	1074-1077	JIC	http://maven.renci.org/NeuroBridge/neurobridge#Thing
9-6	1078-1081	had	_
9-7	1082-1090	temporal	_
9-8	1091-1098	weights	_
9-9	1099-1105	during	_
9-10	1106-1110	N100	_
9-11	1111-1112	(	_
9-12	1113-1120	peaking	_
9-13	1121-1123	at	_
9-14	1124-1127	100	_
9-15	1128-1130	ms	_
9-16	1131-1140	post-tone	_
9-17	1141-1146	onset	_
9-18	1147-1148	)	_
9-19	1149-1152	and	_
9-20	1153-1157	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
9-21	1158-1165	spatial	_
9-22	1166-1173	weights	_
9-23	1174-1176	in	_
9-24	1177-1185	superior	_
9-25	1186-1189	and	_
9-26	1190-1196	middle	_
9-27	1197-1205	temporal	_
9-28	1206-1210	gyri	_
9-29	1211-1212	(	_
9-30	1213-1220	STG/MTG	_
9-31	1221-1222	)	_
9-32	1223-1224	;	_
9-33	1225-1232	however	_
9-34	1233-1234	,	_
9-35	1235-1237	it	_
9-36	1238-1241	did	_
9-37	1242-1245	not	_
9-38	1246-1252	differ	_
9-39	1253-1260	between	_
9-40	1261-1267	groups	_
9-41	1268-1269	.	_

Text=The “ P200 ” JIC had temporal weights during P200 and positive fMRI spatial weights in STG/MTG and frontal areas, and negative spatial weights in the nodes of the default mode network (DMN) and visual cortex.
10-1	1270-1273	The	_
10-2	1274-1275	“	_
10-3	1276-1280	P200	_
10-4	1281-1282	”	_
10-5	1283-1286	JIC	_
10-6	1287-1290	had	_
10-7	1291-1299	temporal	_
10-8	1300-1307	weights	_
10-9	1308-1314	during	_
10-10	1315-1319	P200	_
10-11	1320-1323	and	_
10-12	1324-1332	positive	_
10-13	1333-1337	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
10-14	1338-1345	spatial	_
10-15	1346-1353	weights	_
10-16	1354-1356	in	_
10-17	1357-1364	STG/MTG	_
10-18	1365-1368	and	_
10-19	1369-1376	frontal	_
10-20	1377-1382	areas	_
10-21	1383-1384	,	_
10-22	1385-1388	and	_
10-23	1389-1397	negative	_
10-24	1398-1405	spatial	_
10-25	1406-1413	weights	_
10-26	1414-1416	in	_
10-27	1417-1420	the	_
10-28	1421-1426	nodes	_
10-29	1427-1429	of	_
10-30	1430-1433	the	_
10-31	1434-1441	default	_
10-32	1442-1446	mode	_
10-33	1447-1454	network	_
10-34	1455-1456	(	_
10-35	1457-1460	DMN	_
10-36	1461-1462	)	_
10-37	1463-1466	and	_
10-38	1467-1473	visual	_
10-39	1474-1480	cortex	_
10-40	1481-1482	.	_

Text=Groups differed on the “ P200 ” JIC: SZ had smaller “ P200 ” JIC, especially those with more severe avolition/apathy.
11-1	1483-1489	Groups	_
11-2	1490-1498	differed	_
11-3	1499-1501	on	_
11-4	1502-1505	the	_
11-5	1506-1507	“	_
11-6	1508-1512	P200	_
11-7	1513-1514	”	_
11-8	1515-1518	JIC	_
11-9	1519-1520	:	_
11-10	1521-1523	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
11-11	1524-1527	had	_
11-12	1528-1535	smaller	_
11-13	1536-1537	“	_
11-14	1538-1542	P200	_
11-15	1543-1544	”	_
11-16	1545-1548	JIC	_
11-17	1549-1550	,	_
11-18	1551-1561	especially	_
11-19	1562-1567	those	_
11-20	1568-1572	with	_
11-21	1573-1577	more	_
11-22	1578-1584	severe	_
11-23	1585-1601	avolition/apathy	_
11-24	1602-1603	.	_

Text=This is consistent with negative symptoms being related to perceptual deficits, and suggests patients with avolition/apathy may allocate too few resources to processing external auditory events and too many to processing internal events.
12-1	1604-1608	This	_
12-2	1609-1611	is	_
12-3	1612-1622	consistent	_
12-4	1623-1627	with	_
12-5	1628-1636	negative	_
12-6	1637-1645	symptoms	_
12-7	1646-1651	being	_
12-8	1652-1659	related	_
12-9	1660-1662	to	_
12-10	1663-1673	perceptual	_
12-11	1674-1682	deficits	_
12-12	1683-1684	,	_
12-13	1685-1688	and	_
12-14	1689-1697	suggests	_
12-15	1698-1706	patients	_
12-16	1707-1711	with	_
12-17	1712-1728	avolition/apathy	http://maven.renci.org/NeuroBridge/neurobridge#Location
12-18	1729-1732	may	_
12-19	1733-1741	allocate	_
12-20	1742-1745	too	_
12-21	1746-1749	few	_
12-22	1750-1759	resources	_
12-23	1760-1762	to	_
12-24	1763-1773	processing	_
12-25	1774-1782	external	_
12-26	1783-1791	auditory	_
12-27	1792-1798	events	_
12-28	1799-1802	and	_
12-29	1803-1806	too	_
12-30	1807-1811	many	_
12-31	1812-1814	to	_
12-32	1815-1825	processing	_
12-33	1826-1834	internal	_
12-34	1835-1841	events	_
12-35	1842-1843	.	_

Text=Highlights Perceptual deficits in schizophrenia (SZ) were assessed using concurrent EEG + fMRI.
13-1	1844-1854	Highlights	_
13-2	1855-1865	Perceptual	_
13-3	1866-1874	deficits	_
13-4	1875-1877	in	_
13-5	1878-1891	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
13-6	1892-1893	(	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
13-7	1894-1896	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
13-8	1897-1898	)	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
13-9	1899-1903	were	_
13-10	1904-1912	assessed	_
13-11	1913-1918	using	_
13-12	1919-1929	concurrent	_
13-13	1930-1933	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Thing
13-14	1934-1935	+	http://maven.renci.org/NeuroBridge/neurobridge#Thing
13-15	1936-1940	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
13-16	1941-1942	.	_

Text=Joint independent components (JIC) analysis integrated EEG-based ERP and fMRI data.
14-1	1943-1948	Joint	_
14-2	1949-1960	independent	_
14-3	1961-1971	components	_
14-4	1972-1973	(	_
14-5	1974-1977	JIC	_
14-6	1978-1979	)	_
14-7	1980-1988	analysis	_
14-8	1989-1999	integrated	_
14-9	2000-2009	EEG-based	_
14-10	2010-2013	ERP	_
14-11	2014-2017	and	_
14-12	2018-2022	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
14-13	2023-2027	data	_
14-14	2028-2029	.	_

Text=“ N100 ” and “ P200 ” JICs were associated with auditory cortical activity.
15-1	2030-2031	“	_
15-2	2032-2036	N100	_
15-3	2037-2038	”	_
15-4	2039-2042	and	_
15-5	2043-2044	“	_
15-6	2045-2049	P200	_
15-7	2050-2051	”	_
15-8	2052-2056	JICs	_
15-9	2057-2061	were	_
15-10	2062-2072	associated	_
15-11	2073-2077	with	_
15-12	2078-2086	auditory	_
15-13	2087-2095	cortical	_
15-14	2096-2104	activity	_
15-15	2105-2106	.	_

Text=“ P200 ” JIC was inversely related to visual and default mode network (DMN) activity.
16-1	2107-2108	“	_
16-2	2109-2113	P200	_
16-3	2114-2115	”	_
16-4	2116-2119	JIC	_
16-5	2120-2123	was	_
16-6	2124-2133	inversely	_
16-7	2134-2141	related	_
16-8	2142-2144	to	_
16-9	2145-2151	visual	_
16-10	2152-2155	and	_
16-11	2156-2163	default	_
16-12	2164-2168	mode	_
16-13	2169-2176	network	_
16-14	2177-2178	(	_
16-15	2179-2182	DMN	_
16-16	2183-2184	)	_
16-17	2185-2193	activity	_
16-18	2194-2195	.	_

Text=SZ had smaller “ P200 ” JICs, especially those with severe negative symptoms.
17-1	2196-2198	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
17-2	2199-2202	had	_
17-3	2203-2210	smaller	_
17-4	2211-2212	“	_
17-5	2213-2217	P200	_
17-6	2218-2219	”	_
17-7	2220-2224	JICs	_
17-8	2225-2226	,	_
17-9	2227-2237	especially	_
17-10	2238-2243	those	_
17-11	2244-2248	with	_
17-12	2249-2255	severe	_
17-13	2256-2264	negative	_
17-14	2265-2273	symptoms	_
17-15	2274-2275	.	_

Text=Materials and methods Participants Data are reported here from 30 patients with DSM-IV schizophrenia (N = 24) and schizoaffective disorder (N = 6) (hereinafter referred to as schizophrenia (SZ) patients), and 23 age- and gender-matched healthy comparison (HC) subjects (see below for description of why 8 SZ and 5 HC were dropped from the initial sample of 66 subjects.)
18-1	2276-2285	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
18-2	2286-2289	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
18-3	2290-2297	methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
18-4	2298-2310	Participants	_
18-5	2311-2315	Data	_
18-6	2316-2319	are	_
18-7	2320-2328	reported	_
18-8	2329-2333	here	_
18-9	2334-2338	from	_
18-10	2339-2341	30	_
18-11	2342-2350	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
18-12	2351-2355	with	_
18-13	2356-2362	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
18-14	2363-2376	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
18-15	2377-2378	(	_
18-16	2379-2380	N	_
18-17	2381-2382	=	_
18-18	2383-2385	24	_
18-19	2386-2387	)	_
18-20	2388-2391	and	_
18-21	2392-2407	schizoaffective	http://maven.renci.org/NeuroBridge/neurobridge#BipolarTypeSchizoaffectiveDisorder
18-22	2408-2416	disorder	http://maven.renci.org/NeuroBridge/neurobridge#BipolarTypeSchizoaffectiveDisorder
18-23	2417-2418	(	_
18-24	2419-2420	N	_
18-25	2421-2422	=	_
18-26	2423-2424	6	_
18-27	2425-2426	)	_
18-28	2427-2428	(	_
18-29	2429-2440	hereinafter	_
18-30	2441-2449	referred	_
18-31	2450-2452	to	_
18-32	2453-2455	as	_
18-33	2456-2469	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
18-34	2470-2471	(	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
18-35	2472-2474	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
18-36	2475-2476	)	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
18-37	2477-2485	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
18-38	2486-2487	)	_
18-39	2488-2489	,	_
18-40	2490-2493	and	_
18-41	2494-2496	23	_
18-42	2497-2501	age-	_
18-43	2502-2505	and	_
18-44	2506-2520	gender-matched	_
18-45	2521-2528	healthy	http://maven.renci.org/NeuroBridge/neurobridge#Comparison
18-46	2529-2539	comparison	http://maven.renci.org/NeuroBridge/neurobridge#Comparison
18-47	2540-2541	(	_
18-48	2542-2544	HC	_
18-49	2545-2546	)	_
18-50	2547-2555	subjects	_
18-51	2556-2557	(	_
18-52	2558-2561	see	_
18-53	2562-2567	below	_
18-54	2568-2571	for	_
18-55	2572-2583	description	_
18-56	2584-2586	of	_
18-57	2587-2590	why	_
18-58	2591-2592	8	_
18-59	2593-2595	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
18-60	2596-2599	and	_
18-61	2600-2601	5	_
18-62	2602-2604	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
18-63	2605-2609	were	_
18-64	2610-2617	dropped	_
18-65	2618-2622	from	_
18-66	2623-2626	the	_
18-67	2627-2634	initial	_
18-68	2635-2641	sample	_
18-69	2642-2644	of	_
18-70	2645-2647	66	_
18-71	2648-2656	subjects	_
18-72	2657-2658	.	_
18-73	2659-2660	)	_

Text=Diagnoses were based on the Structured Clinical Interview for DSM-IV.
19-1	2661-2670	Diagnoses	_
19-2	2671-2675	were	_
19-3	2676-2681	based	_
19-4	2682-2684	on	_
19-5	2685-2688	the	_
19-6	2689-2699	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
19-7	2700-2708	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
19-8	2709-2718	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
19-9	2719-2722	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
19-10	2723-2729	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
19-11	2730-2731	.	_

Text=Community outpatient clinicians referred SZ to us; both groups were recruited by advertisements and word of mouth.
20-1	2732-2741	Community	_
20-2	2742-2752	outpatient	_
20-3	2753-2763	clinicians	_
20-4	2764-2772	referred	_
20-5	2773-2775	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
20-6	2776-2778	to	_
20-7	2779-2781	us	_
20-8	2782-2783	;	_
20-9	2784-2788	both	_
20-10	2789-2795	groups	_
20-11	2796-2800	were	_
20-12	2801-2810	recruited	_
20-13	2811-2813	by	_
20-14	2814-2828	advertisements	_
20-15	2829-2832	and	_
20-16	2833-2837	word	_
20-17	2838-2840	of	_
20-18	2841-2846	mouth	_
20-19	2847-2848	.	_

Text=Exclusion criteria for HC included any past or current major DSM-IV Axis I disorder based on a Structured Clinical Interview for DSM-IV Disorders, or having a first-degree relative with a psychotic disorder.
21-1	2849-2858	Exclusion	_
21-2	2859-2867	criteria	_
21-3	2868-2871	for	_
21-4	2872-2874	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
21-5	2875-2883	included	_
21-6	2884-2887	any	_
21-7	2888-2892	past	_
21-8	2893-2895	or	_
21-9	2896-2903	current	_
21-10	2904-2909	major	_
21-11	2910-2916	DSM-IV	_
21-12	2917-2921	Axis	_
21-13	2922-2923	I	_
21-14	2924-2932	disorder	_
21-15	2933-2938	based	_
21-16	2939-2941	on	_
21-17	2942-2943	a	_
21-18	2944-2954	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
21-19	2955-2963	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
21-20	2964-2973	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
21-21	2974-2977	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
21-22	2978-2984	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
21-23	2985-2994	Disorders	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
21-24	2995-2996	,	_
21-25	2997-2999	or	_
21-26	3000-3006	having	_
21-27	3007-3008	a	_
21-28	3009-3021	first-degree	_
21-29	3022-3030	relative	_
21-30	3031-3035	with	_
21-31	3036-3037	a	_
21-32	3038-3047	psychotic	_
21-33	3048-3056	disorder	_
21-34	3057-3058	.	_

Text=For both groups, exclusion criteria were a history of a significant medical or neurological illness, head injury resulting in loss of consciousness, or substance abuse in the past 3 months.
22-1	3059-3062	For	_
22-2	3063-3067	both	_
22-3	3068-3074	groups	_
22-4	3075-3076	,	_
22-5	3077-3086	exclusion	_
22-6	3087-3095	criteria	_
22-7	3096-3100	were	_
22-8	3101-3102	a	_
22-9	3103-3110	history	_
22-10	3111-3113	of	_
22-11	3114-3115	a	_
22-12	3116-3127	significant	_
22-13	3128-3135	medical	_
22-14	3136-3138	or	_
22-15	3139-3151	neurological	_
22-16	3152-3159	illness	_
22-17	3160-3161	,	_
22-18	3162-3166	head	_
22-19	3167-3173	injury	_
22-20	3174-3183	resulting	_
22-21	3184-3186	in	_
22-22	3187-3191	loss	_
22-23	3192-3194	of	_
22-24	3195-3208	consciousness	_
22-25	3209-3210	,	_
22-26	3211-3213	or	_
22-27	3214-3223	substance	_
22-28	3224-3229	abuse	_
22-29	3230-3232	in	_
22-30	3233-3236	the	_
22-31	3237-3241	past	_
22-32	3242-3243	3	_
22-33	3244-3250	months	_
22-34	3251-3252	.	_

Text=Additionally, HC did not have history of substance dependence (except nicotine), whereas SZ did not meet criteria for substance dependence within the past year.
23-1	3253-3265	Additionally	_
23-2	3266-3267	,	_
23-3	3268-3270	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
23-4	3271-3274	did	_
23-5	3275-3278	not	_
23-6	3279-3283	have	_
23-7	3284-3291	history	_
23-8	3292-3294	of	_
23-9	3295-3304	substance	_
23-10	3305-3315	dependence	_
23-11	3316-3317	(	_
23-12	3318-3324	except	_
23-13	3325-3333	nicotine	_
23-14	3334-3335	)	_
23-15	3336-3337	,	_
23-16	3338-3345	whereas	_
23-17	3346-3348	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
23-18	3349-3352	did	_
23-19	3353-3356	not	_
23-20	3357-3361	meet	_
23-21	3362-3370	criteria	_
23-22	3371-3374	for	_
23-23	3375-3384	substance	_
23-24	3385-3395	dependence	_
23-25	3396-3402	within	_
23-26	3403-3406	the	_
23-27	3407-3411	past	_
23-28	3412-3416	year	_
23-29	3417-3418	.	_

Text=A psychiatrist or clinical psychologist conducted all interviews.
24-1	3419-3420	A	_
24-2	3421-3433	psychiatrist	_
24-3	3434-3436	or	_
24-4	3437-3445	clinical	_
24-5	3446-3458	psychologist	_
24-6	3459-3468	conducted	_
24-7	3469-3472	all	_
24-8	3473-3483	interviews	_
24-9	3484-3485	.	_

Text=Institutional Review Boards at the University of California at San Francisco and the San Francisco Veterans Affairs Medical Center approved the study, and all participants provided written informed consent.
25-1	3486-3499	Institutional	_
25-2	3500-3506	Review	_
25-3	3507-3513	Boards	_
25-4	3514-3516	at	_
25-5	3517-3520	the	_
25-6	3521-3531	University	_
25-7	3532-3534	of	_
25-8	3535-3545	California	_
25-9	3546-3548	at	_
25-10	3549-3552	San	_
25-11	3553-3562	Francisco	_
25-12	3563-3566	and	_
25-13	3567-3570	the	_
25-14	3571-3574	San	_
25-15	3575-3584	Francisco	_
25-16	3585-3593	Veterans	_
25-17	3594-3601	Affairs	_
25-18	3602-3609	Medical	_
25-19	3610-3616	Center	_
25-20	3617-3625	approved	_
25-21	3626-3629	the	_
25-22	3630-3635	study	_
25-23	3636-3637	,	_
25-24	3638-3641	and	_
25-25	3642-3645	all	_
25-26	3646-3658	participants	_
25-27	3659-3667	provided	_
25-28	3668-3675	written	_
25-29	3676-3684	informed	_
25-30	3685-3692	consent	_
25-31	3693-3694	.	_

Text=Clinical and demographic data are presented in Table 1 for those subjects included in the final analysis.
26-1	3695-3703	Clinical	_
26-2	3704-3707	and	_
26-3	3708-3719	demographic	_
26-4	3720-3724	data	_
26-5	3725-3728	are	_
26-6	3729-3738	presented	_
26-7	3739-3741	in	_
26-8	3742-3747	Table	_
26-9	3748-3749	1	_
26-10	3750-3753	for	_
26-11	3754-3759	those	_
26-12	3760-3768	subjects	_
26-13	3769-3777	included	_
26-14	3778-3780	in	_
26-15	3781-3784	the	_
26-16	3785-3790	final	_
26-17	3791-3799	analysis	_
26-18	3800-3801	.	_

Text=Clinical ratings A trained research assistant, along with a psychiatrist or clinical psychologist, rated schizophrenia symptoms using the Scale for the Assessment of Positive Symptoms (SAPS) and the Scale for the Assessment of Negative Symptoms (SANS).
27-1	3802-3810	Clinical	_
27-2	3811-3818	ratings	_
27-3	3819-3820	A	_
27-4	3821-3828	trained	_
27-5	3829-3837	research	_
27-6	3838-3847	assistant	_
27-7	3848-3849	,	_
27-8	3850-3855	along	_
27-9	3856-3860	with	_
27-10	3861-3862	a	_
27-11	3863-3875	psychiatrist	_
27-12	3876-3878	or	_
27-13	3879-3887	clinical	_
27-14	3888-3900	psychologist	_
27-15	3901-3902	,	_
27-16	3903-3908	rated	_
27-17	3909-3922	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
27-18	3923-3931	symptoms	_
27-19	3932-3937	using	_
27-20	3938-3941	the	_
27-21	3942-3947	Scale	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
27-22	3948-3951	for	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
27-23	3952-3955	the	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
27-24	3956-3966	Assessment	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
27-25	3967-3969	of	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
27-26	3970-3978	Positive	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
27-27	3979-3987	Symptoms	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
27-28	3988-3989	(	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
27-29	3990-3994	SAPS	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
27-30	3995-3996	)	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
27-31	3997-4000	and	_
27-32	4001-4004	the	_
27-33	4005-4010	Scale	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
27-34	4011-4014	for	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
27-35	4015-4018	the	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
27-36	4019-4029	Assessment	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
27-37	4030-4032	of	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
27-38	4033-4041	Negative	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
27-39	4042-4050	Symptoms	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
27-40	4051-4052	(	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
27-41	4053-4057	SANS	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
27-42	4058-4059	)	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
27-43	4060-4061	.	_

Text=Experimental tasks Subjects were instructed to, “ Rest with your eyes open, look at a fixation cross, and listen to the sequence of tones you just generated. ” They listened to a series of 500 ms, 1000 Hz tones, presented in 16 seconds (s) blocks alternating with 16 s blocks of rest.
28-1	4062-4074	Experimental	_
28-2	4075-4080	tasks	_
28-3	4081-4089	Subjects	_
28-4	4090-4094	were	_
28-5	4095-4105	instructed	_
28-6	4106-4108	to	_
28-7	4109-4110	,	_
28-8	4111-4112	“	_
28-9	4113-4117	Rest	_
28-10	4118-4122	with	_
28-11	4123-4127	your	_
28-12	4128-4132	eyes	_
28-13	4133-4137	open	_
28-14	4138-4139	,	_
28-15	4140-4144	look	_
28-16	4145-4147	at	_
28-17	4148-4149	a	_
28-18	4150-4158	fixation	_
28-19	4159-4164	cross	_
28-20	4165-4166	,	_
28-21	4167-4170	and	_
28-22	4171-4177	listen	_
28-23	4178-4180	to	_
28-24	4181-4184	the	_
28-25	4185-4193	sequence	_
28-26	4194-4196	of	_
28-27	4197-4202	tones	_
28-28	4203-4206	you	_
28-29	4207-4211	just	_
28-30	4212-4222	generated.	_
28-31	4223-4224	”	_
28-32	4225-4229	They	_
28-33	4230-4238	listened	_
28-34	4239-4241	to	_
28-35	4242-4243	a	_
28-36	4244-4250	series	_
28-37	4251-4253	of	_
28-38	4254-4257	500	_
28-39	4258-4260	ms	_
28-40	4261-4262	,	_
28-41	4263-4267	1000	_
28-42	4268-4270	Hz	_
28-43	4271-4276	tones	_
28-44	4277-4278	,	_
28-45	4279-4288	presented	_
28-46	4289-4291	in	_
28-47	4292-4294	16	_
28-48	4295-4302	seconds	_
28-49	4303-4304	(	_
28-50	4305-4306	s	_
28-51	4307-4308	)	_
28-52	4309-4315	blocks	_
28-53	4316-4327	alternating	_
28-54	4328-4332	with	_
28-55	4333-4335	16	_
28-56	4336-4337	s	_
28-57	4338-4344	blocks	_
28-58	4345-4347	of	_
28-59	4348-4352	rest	_
28-60	4353-4354	.	_

Text=The first and last rest blocks lasted 30 s each to facilitate EEG artifact correction procedures described below.
29-1	4355-4358	The	_
29-2	4359-4364	first	_
29-3	4365-4368	and	_
29-4	4369-4373	last	_
29-5	4374-4378	rest	_
29-6	4379-4385	blocks	_
29-7	4386-4392	lasted	_
29-8	4393-4395	30	_
29-9	4396-4397	s	_
29-10	4398-4402	each	_
29-11	4403-4405	to	_
29-12	4406-4416	facilitate	_
29-13	4417-4420	EEG	_
29-14	4421-4429	artifact	_
29-15	4430-4440	correction	_
29-16	4441-4451	procedures	_
29-17	4452-4461	described	_
29-18	4462-4467	below	_
29-19	4468-4469	.	_

Text=There were two runs with 10 Listen and 10 Rest blocks.
30-1	4470-4475	There	_
30-2	4476-4480	were	_
30-3	4481-4484	two	_
30-4	4485-4489	runs	_
30-5	4490-4494	with	_
30-6	4495-4497	10	_
30-7	4498-4504	Listen	_
30-8	4505-4508	and	_
30-9	4509-4511	10	_
30-10	4512-4516	Rest	_
30-11	4517-4523	blocks	_
30-12	4524-4525	.	_

Text=The individual sequences of tones presented during the Listen task had been generated by each subject earlier when subjects pressed a button every 1 to 2 s to deliver a tone (the Self task).
31-1	4526-4529	The	_
31-2	4530-4540	individual	_
31-3	4541-4550	sequences	_
31-4	4551-4553	of	_
31-5	4554-4559	tones	_
31-6	4560-4569	presented	_
31-7	4570-4576	during	_
31-8	4577-4580	the	_
31-9	4581-4587	Listen	_
31-10	4588-4592	task	_
31-11	4593-4596	had	_
31-12	4597-4601	been	_
31-13	4602-4611	generated	_
31-14	4612-4614	by	_
31-15	4615-4619	each	_
31-16	4620-4627	subject	_
31-17	4628-4635	earlier	_
31-18	4636-4640	when	_
31-19	4641-4649	subjects	_
31-20	4650-4657	pressed	_
31-21	4658-4659	a	_
31-22	4660-4666	button	_
31-23	4667-4672	every	_
31-24	4673-4674	1	_
31-25	4675-4677	to	_
31-26	4678-4679	2	_
31-27	4680-4681	s	_
31-28	4682-4684	to	_
31-29	4685-4692	deliver	_
31-30	4693-4694	a	_
31-31	4695-4699	tone	_
31-32	4700-4701	(	_
31-33	4702-4705	the	_
31-34	4706-4710	Self	_
31-35	4711-4715	task	_
31-36	4716-4717	)	_
31-37	4718-4719	.	_

Text=EEG responses to tones collected in the MR scanner during the Self task cannot be analyzed because a button press artifact occurs in the EEG at the exact moment of tone onset.
32-1	4720-4723	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
32-2	4724-4733	responses	_
32-3	4734-4736	to	_
32-4	4737-4742	tones	_
32-5	4743-4752	collected	_
32-6	4753-4755	in	_
32-7	4756-4759	the	_
32-8	4760-4762	MR	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
32-9	4763-4770	scanner	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
32-10	4771-4777	during	_
32-11	4778-4781	the	_
32-12	4782-4786	Self	_
32-13	4787-4791	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
32-14	4792-4795	can	_
32-15	4796-4799	not	_
32-16	4800-4802	be	_
32-17	4803-4811	analyzed	_
32-18	4812-4819	because	_
32-19	4820-4821	a	_
32-20	4822-4828	button	_
32-21	4829-4834	press	_
32-22	4835-4843	artifact	_
32-23	4844-4850	occurs	_
32-24	4851-4853	in	_
32-25	4854-4857	the	_
32-26	4858-4861	EEG	_
32-27	4862-4864	at	_
32-28	4865-4868	the	_
32-29	4869-4874	exact	_
32-30	4875-4881	moment	_
32-31	4882-4884	of	_
32-32	4885-4889	tone	_
32-33	4890-4895	onset	_
32-34	4896-4897	.	_

Text=However, the fMRI data were not affected and will be described in a separate paper.
33-1	4898-4905	However	_
33-2	4906-4907	,	_
33-3	4908-4911	the	_
33-4	4912-4916	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
33-5	4917-4921	data	_
33-6	4922-4926	were	_
33-7	4927-4930	not	_
33-8	4931-4939	affected	_
33-9	4940-4943	and	_
33-10	4944-4948	will	_
33-11	4949-4951	be	_
33-12	4952-4961	described	_
33-13	4962-4964	in	_
33-14	4965-4966	a	_
33-15	4967-4975	separate	_
33-16	4976-4981	paper	_
33-17	4982-4983	.	_

Text=There were no significant differences in the number of tones between the groups, t (51) = 0.80, p = 0.43; HC (mean = 182 ± 35), SZ (mean = 171 ± 58).
34-1	4984-4989	There	_
34-2	4990-4994	were	_
34-3	4995-4997	no	_
34-4	4998-5009	significant	_
34-5	5010-5021	differences	_
34-6	5022-5024	in	_
34-7	5025-5028	the	_
34-8	5029-5035	number	_
34-9	5036-5038	of	_
34-10	5039-5044	tones	_
34-11	5045-5052	between	_
34-12	5053-5056	the	_
34-13	5057-5063	groups	_
34-14	5064-5065	,	_
34-15	5066-5067	t	_
34-16	5068-5069	(	_
34-17	5070-5072	51	_
34-18	5073-5074	)	_
34-19	5075-5076	=	_
34-20	5077-5081	0.80	_
34-21	5082-5083	,	_
34-22	5084-5085	p	_
34-23	5086-5087	=	_
34-24	5088-5092	0.43	_
34-25	5093-5094	;	_
34-26	5095-5097	HC	_
34-27	5098-5099	(	_
34-28	5100-5104	mean	_
34-29	5105-5106	=	_
34-30	5107-5110	182	_
34-31	5111-5112	±	_
34-32	5113-5115	35	_
34-33	5116-5117	)	_
34-34	5118-5119	,	_
34-35	5120-5122	SZ	_
34-36	5123-5124	(	_
34-37	5125-5129	mean	_
34-38	5130-5131	=	_
34-39	5132-5135	171	_
34-40	5136-5137	±	_
34-41	5138-5140	58	_
34-42	5141-5142	)	_
34-43	5143-5144	.	_

Text=The interval between tones (in seconds) also did not differ between groups, t (51) = − 1.3, p = 0.22, HC (mean = 0.95 ± 0.22), SZ (mean = 1.05 ± 0.35).
35-1	5145-5148	The	_
35-2	5149-5157	interval	_
35-3	5158-5165	between	_
35-4	5166-5171	tones	_
35-5	5172-5173	(	_
35-6	5174-5176	in	_
35-7	5177-5184	seconds	_
35-8	5185-5186	)	_
35-9	5187-5191	also	_
35-10	5192-5195	did	_
35-11	5196-5199	not	_
35-12	5200-5206	differ	_
35-13	5207-5214	between	_
35-14	5215-5221	groups	_
35-15	5222-5223	,	_
35-16	5224-5225	t	_
35-17	5226-5227	(	_
35-18	5228-5230	51	_
35-19	5231-5232	)	_
35-20	5233-5234	=	_
35-21	5235-5236	−	_
35-22	5237-5240	1.3	_
35-23	5241-5242	,	_
35-24	5243-5244	p	_
35-25	5245-5246	=	_
35-26	5247-5251	0.22	_
35-27	5252-5253	,	_
35-28	5254-5256	HC	_
35-29	5257-5258	(	_
35-30	5259-5263	mean	_
35-31	5264-5265	=	_
35-32	5266-5270	0.95	_
35-33	5271-5272	±	_
35-34	5273-5277	0.22	_
35-35	5278-5279	)	_
35-36	5280-5281	,	_
35-37	5282-5284	SZ	_
35-38	5285-5286	(	_
35-39	5287-5291	mean	_
35-40	5292-5293	=	_
35-41	5294-5298	1.05	_
35-42	5299-5300	±	_
35-43	5301-5305	0.35	_
35-44	5306-5307	)	_
35-45	5308-5309	.	_

Text=MRI data acquisition, preprocessing and analysis We collected structural and functional MRI data using a 3 T Siemens Skyra scanner.
36-1	5310-5313	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
36-2	5314-5318	data	_
36-3	5319-5330	acquisition	_
36-4	5331-5332	,	_
36-5	5333-5346	preprocessing	_
36-6	5347-5350	and	_
36-7	5351-5359	analysis	_
36-8	5360-5362	We	_
36-9	5363-5372	collected	_
36-10	5373-5383	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
36-11	5384-5387	and	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
36-12	5388-5398	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
36-13	5399-5402	MRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
36-14	5403-5407	data	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
36-15	5408-5413	using	_
36-16	5414-5415	a	_
36-17	5416-5417	3	_
36-18	5418-5419	T	http://maven.renci.org/NeuroBridge/neurobridge#2Level
36-19	5420-5427	Siemens	http://maven.renci.org/NeuroBridge/neurobridge#2Level
36-20	5428-5433	Skyra	http://maven.renci.org/NeuroBridge/neurobridge#2Level
36-21	5434-5441	scanner	http://maven.renci.org/NeuroBridge/neurobridge#2Level
36-22	5442-5443	.	_

Text=The structural imaging protocol was a magnetization-prepared rapid gradient-echo (MPRAGE) T1-weighted high-resolution image (2300 ms TR, 2.98 ms TE, 1.20 mm slice thickness, 256 mm field of view, 1.0 × 1.0 × 1.2 voxel size, flip angle 9°, sagittal orientation, 9:14 min).
37-1	5444-5447	The	_
37-2	5448-5458	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
37-3	5459-5466	imaging	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
37-4	5467-5475	protocol	_
37-5	5476-5479	was	_
37-6	5480-5481	a	_
37-7	5482-5504	magnetization-prepared	_
37-8	5505-5510	rapid	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
37-9	5511-5524	gradient-echo	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
37-10	5525-5526	(	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
37-11	5527-5533	MPRAGE	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
37-12	5534-5535	)	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
37-13	5536-5547	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
37-14	5548-5563	high-resolution	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
37-15	5564-5569	image	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
37-16	5570-5571	(	_
37-17	5572-5576	2300	_
37-18	5577-5579	ms	_
37-19	5580-5582	TR	_
37-20	5583-5584	,	_
37-21	5585-5589	2.98	_
37-22	5590-5592	ms	_
37-23	5593-5595	TE	_
37-24	5596-5597	,	_
37-25	5598-5602	1.20	_
37-26	5603-5605	mm	_
37-27	5606-5611	slice	_
37-28	5612-5621	thickness	_
37-29	5622-5623	,	_
37-30	5624-5627	256	_
37-31	5628-5630	mm	_
37-32	5631-5636	field	_
37-33	5637-5639	of	_
37-34	5640-5644	view	_
37-35	5645-5646	,	_
37-36	5647-5650	1.0	_
37-37	5651-5652	×	_
37-38	5653-5656	1.0	_
37-39	5657-5658	×	_
37-40	5659-5662	1.2	_
37-41	5663-5668	voxel	_
37-42	5669-5673	size	_
37-43	5674-5675	,	_
37-44	5676-5680	flip	_
37-45	5681-5686	angle	_
37-46	5687-5689	9°	_
37-47	5690-5691	,	_
37-48	5692-5700	sagittal	_
37-49	5701-5712	orientation	_
37-50	5713-5714	,	_
37-51	5715-5719	9:14	_
37-52	5720-5723	min	_
37-53	5724-5725	)	_
37-54	5726-5727	.	_

Text=The fMRI protocol was an AC-PC aligned echo planar imaging (EPI) sequence (2000 ms TR, 30 ms TE, flip angle 77°, 30 slices collected sequentially in ascending order, 3.4 × 3.4 × 4.0 mm voxel size, 182 frames, 6:08 min).
38-1	5728-5731	The	_
38-2	5732-5736	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
38-3	5737-5745	protocol	_
38-4	5746-5749	was	_
38-5	5750-5752	an	_
38-6	5753-5758	AC-PC	_
38-7	5759-5766	aligned	_
38-8	5767-5771	echo	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
38-9	5772-5778	planar	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
38-10	5779-5786	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
38-11	5787-5788	(	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
38-12	5789-5792	EPI	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
38-13	5793-5794	)	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
38-14	5795-5803	sequence	_
38-15	5804-5805	(	_
38-16	5806-5810	2000	_
38-17	5811-5813	ms	_
38-18	5814-5816	TR	_
38-19	5817-5818	,	_
38-20	5819-5821	30	_
38-21	5822-5824	ms	_
38-22	5825-5827	TE	_
38-23	5828-5829	,	_
38-24	5830-5834	flip	_
38-25	5835-5840	angle	_
38-26	5841-5844	77°	_
38-27	5845-5846	,	_
38-28	5847-5849	30	_
38-29	5850-5856	slices	_
38-30	5857-5866	collected	_
38-31	5867-5879	sequentially	_
38-32	5880-5882	in	_
38-33	5883-5892	ascending	_
38-34	5893-5898	order	_
38-35	5899-5900	,	_
38-36	5901-5904	3.4	_
38-37	5905-5906	×	_
38-38	5907-5910	3.4	_
38-39	5911-5912	×	_
38-40	5913-5916	4.0	_
38-41	5917-5919	mm	_
38-42	5920-5925	voxel	_
38-43	5926-5930	size	_
38-44	5931-5932	,	_
38-45	5933-5936	182	_
38-46	5937-5943	frames	_
38-47	5944-5945	,	_
38-48	5946-5950	6:08	_
38-49	5951-5954	min	_
38-50	5955-5956	)	_
38-51	5957-5958	.	_

Text=Image preprocessing was done using Statistical Parametric Mapping 8 (SPM8; http: //www.fil.ion.ucl.ac.uk/spm/software/spm8/).
39-1	5959-5964	Image	_
39-2	5965-5978	preprocessing	_
39-3	5979-5982	was	_
39-4	5983-5987	done	_
39-5	5988-5993	using	_
39-6	5994-6005	Statistical	_
39-7	6006-6016	Parametric	_
39-8	6017-6024	Mapping	_
39-9	6025-6026	8	_
39-10	6027-6028	(	_
39-11	6029-6033	SPM8	_
39-12	6034-6035	;	_
39-13	6036-6040	http	_
39-14	6041-6042	:	_
39-15	6043-6085	//www.fil.ion.ucl.ac.uk/spm/software/spm8/	_
39-16	6086-6087	)	_
39-17	6088-6089	.	_

Text=First, motion correction was performed via affine registration of all runs, where the first image of each run was realigned to the first image of the first run, and then re-alignment proceeded within each run.
40-1	6090-6095	First	_
40-2	6096-6097	,	_
40-3	6098-6104	motion	_
40-4	6105-6115	correction	_
40-5	6116-6119	was	_
40-6	6120-6129	performed	_
40-7	6130-6133	via	_
40-8	6134-6140	affine	_
40-9	6141-6153	registration	_
40-10	6154-6156	of	_
40-11	6157-6160	all	_
40-12	6161-6165	runs	_
40-13	6166-6167	,	_
40-14	6168-6173	where	_
40-15	6174-6177	the	_
40-16	6178-6183	first	_
40-17	6184-6189	image	_
40-18	6190-6192	of	_
40-19	6193-6197	each	_
40-20	6198-6201	run	_
40-21	6202-6205	was	_
40-22	6206-6215	realigned	_
40-23	6216-6218	to	_
40-24	6219-6222	the	_
40-25	6223-6228	first	_
40-26	6229-6234	image	_
40-27	6235-6237	of	_
40-28	6238-6241	the	_
40-29	6242-6247	first	_
40-30	6248-6251	run	_
40-31	6252-6253	,	_
40-32	6254-6257	and	_
40-33	6258-6262	then	_
40-34	6263-6275	re-alignment	_
40-35	6276-6285	proceeded	_
40-36	6286-6292	within	_
40-37	6293-6297	each	_
40-38	6298-6301	run	_
40-39	6302-6303	.	_

Text=Next, images were slice-time corrected with respect to the middle slice to adjust for timing differences of individual slices within each TR.
41-1	6304-6308	Next	_
41-2	6309-6310	,	_
41-3	6311-6317	images	_
41-4	6318-6322	were	_
41-5	6323-6333	slice-time	_
41-6	6334-6343	corrected	_
41-7	6344-6348	with	_
41-8	6349-6356	respect	_
41-9	6357-6359	to	_
41-10	6360-6363	the	_
41-11	6364-6370	middle	_
41-12	6371-6376	slice	_
41-13	6377-6379	to	_
41-14	6380-6386	adjust	_
41-15	6387-6390	for	_
41-16	6391-6397	timing	_
41-17	6398-6409	differences	_
41-18	6410-6412	of	_
41-19	6413-6423	individual	_
41-20	6424-6430	slices	_
41-21	6431-6437	within	_
41-22	6438-6442	each	_
41-23	6443-6445	TR	_
41-24	6446-6447	.	_

Text=To further denoise the data, we implemented aCompCor (anatomic component based noise correction), a principal components-based approach to noise reduction of fMRI time-series data.
42-1	6448-6450	To	_
42-2	6451-6458	further	_
42-3	6459-6466	denoise	_
42-4	6467-6470	the	_
42-5	6471-6475	data	_
42-6	6476-6477	,	_
42-7	6478-6480	we	_
42-8	6481-6492	implemented	_
42-9	6493-6501	aCompCor	_
42-10	6502-6503	(	_
42-11	6504-6512	anatomic	_
42-12	6513-6522	component	_
42-13	6523-6528	based	_
42-14	6529-6534	noise	_
42-15	6535-6545	correction	_
42-16	6546-6547	)	_
42-17	6548-6549	,	_
42-18	6550-6551	a	_
42-19	6552-6561	principal	_
42-20	6562-6578	components-based	_
42-21	6579-6587	approach	_
42-22	6588-6590	to	_
42-23	6591-6596	noise	_
42-24	6597-6606	reduction	_
42-25	6607-6609	of	_
42-26	6610-6614	fMRI	_
42-27	6615-6626	time-series	_
42-28	6627-6631	data	_
42-29	6632-6633	.	_

Text=ACompCor derives principal components from the time series of voxels within noise regions of interest (ROIs) defined on eroded white matter and cerebrospinal fluid (CSF) parcels from participants' segmented high-resolution T1-weighted anatomical images.
43-1	6634-6642	ACompCor	_
43-2	6643-6650	derives	_
43-3	6651-6660	principal	_
43-4	6661-6671	components	_
43-5	6672-6676	from	_
43-6	6677-6680	the	_
43-7	6681-6685	time	_
43-8	6686-6692	series	_
43-9	6693-6695	of	_
43-10	6696-6702	voxels	_
43-11	6703-6709	within	_
43-12	6710-6715	noise	_
43-13	6716-6723	regions	_
43-14	6724-6726	of	_
43-15	6727-6735	interest	_
43-16	6736-6737	(	_
43-17	6738-6742	ROIs	_
43-18	6743-6744	)	_
43-19	6745-6752	defined	_
43-20	6753-6755	on	_
43-21	6756-6762	eroded	_
43-22	6763-6768	white	_
43-23	6769-6775	matter	_
43-24	6776-6779	and	_
43-25	6780-6793	cerebrospinal	_
43-26	6794-6799	fluid	_
43-27	6800-6801	(	_
43-28	6802-6805	CSF	_
43-29	6806-6807	)	_
43-30	6808-6815	parcels	_
43-31	6816-6820	from	_
43-32	6821-6833	participants	_
43-33	6834-6835	'	_
43-34	6836-6845	segmented	_
43-35	6846-6861	high-resolution	_
43-36	6862-6873	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
43-37	6874-6884	anatomical	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
43-38	6885-6891	images	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
43-39	6892-6893	.	_

Text=To derive these white matter and CSF noise ROIs, the structural MRI scan was segmented using SPM 8, yielding a white matter map that was thresholded at p> 0.99 and eroded by 2 voxels, and a CSF map that was thresholded at p> 0.9 and eroded using a 3D nearest neighbor clustering criterion of at least two neighbors.
44-1	6894-6896	To	_
44-2	6897-6903	derive	_
44-3	6904-6909	these	_
44-4	6910-6915	white	_
44-5	6916-6922	matter	_
44-6	6923-6926	and	_
44-7	6927-6930	CSF	_
44-8	6931-6936	noise	_
44-9	6937-6941	ROIs	_
44-10	6942-6943	,	_
44-11	6944-6947	the	_
44-12	6948-6958	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
44-13	6959-6962	MRI	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
44-14	6963-6967	scan	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
44-15	6968-6971	was	_
44-16	6972-6981	segmented	_
44-17	6982-6987	using	_
44-18	6988-6991	SPM	_
44-19	6992-6993	8	_
44-20	6994-6995	,	_
44-21	6996-7004	yielding	_
44-22	7005-7006	a	_
44-23	7007-7012	white	_
44-24	7013-7019	matter	_
44-25	7020-7023	map	_
44-26	7024-7028	that	_
44-27	7029-7032	was	_
44-28	7033-7044	thresholded	_
44-29	7045-7047	at	_
44-30	7048-7049	p	_
44-31	7050-7051	>	_
44-32	7052-7056	0.99	_
44-33	7057-7060	and	_
44-34	7061-7067	eroded	_
44-35	7068-7070	by	_
44-36	7071-7072	2	_
44-37	7073-7079	voxels	_
44-38	7080-7081	,	_
44-39	7082-7085	and	_
44-40	7086-7087	a	_
44-41	7088-7091	CSF	_
44-42	7092-7095	map	_
44-43	7096-7100	that	_
44-44	7101-7104	was	_
44-45	7105-7116	thresholded	_
44-46	7117-7119	at	_
44-47	7120-7121	p	_
44-48	7122-7123	>	_
44-49	7124-7127	0.9	_
44-50	7128-7131	and	_
44-51	7132-7138	eroded	_
44-52	7139-7144	using	_
44-53	7145-7146	a	_
44-54	7147-7149	3D	_
44-55	7150-7157	nearest	_
44-56	7158-7166	neighbor	_
44-57	7167-7177	clustering	_
44-58	7178-7187	criterion	_
44-59	7188-7190	of	_
44-60	7191-7193	at	_
44-61	7194-7199	least	_
44-62	7200-7203	two	_
44-63	7204-7213	neighbors	_
44-64	7214-7215	.	_

Text=A binary union mask of these white matter and CSF noise ROIs was generated and co-registered to the mean functional scan.
45-1	7216-7217	A	_
45-2	7218-7224	binary	_
45-3	7225-7230	union	_
45-4	7231-7235	mask	_
45-5	7236-7238	of	_
45-6	7239-7244	these	_
45-7	7245-7250	white	_
45-8	7251-7257	matter	_
45-9	7258-7261	and	_
45-10	7262-7265	CSF	_
45-11	7266-7271	noise	_
45-12	7272-7276	ROIs	_
45-13	7277-7280	was	_
45-14	7281-7290	generated	_
45-15	7291-7294	and	_
45-16	7295-7308	co-registered	_
45-17	7309-7311	to	_
45-18	7312-7315	the	_
45-19	7316-7320	mean	_
45-20	7321-7331	functional	_
45-21	7332-7336	scan	_
45-22	7337-7338	.	_

Text=Before proceeding with a principal component analysis (PCA) of the functional time series data of voxels contained in this co-registered white matter/CSF noise ROI mask, voxels in the mask that showed even weak relationships with the task regressors (p <0.2) were excluded.
46-1	7339-7345	Before	_
46-2	7346-7356	proceeding	_
46-3	7357-7361	with	_
46-4	7362-7363	a	_
46-5	7364-7373	principal	_
46-6	7374-7383	component	_
46-7	7384-7392	analysis	_
46-8	7393-7394	(	_
46-9	7395-7398	PCA	_
46-10	7399-7400	)	_
46-11	7401-7403	of	_
46-12	7404-7407	the	_
46-13	7408-7418	functional	_
46-14	7419-7423	time	_
46-15	7424-7430	series	_
46-16	7431-7435	data	_
46-17	7436-7438	of	_
46-18	7439-7445	voxels	_
46-19	7446-7455	contained	_
46-20	7456-7458	in	_
46-21	7459-7463	this	_
46-22	7464-7477	co-registered	_
46-23	7478-7483	white	_
46-24	7484-7494	matter/CSF	_
46-25	7495-7500	noise	_
46-26	7501-7504	ROI	_
46-27	7505-7509	mask	_
46-28	7510-7511	,	_
46-29	7512-7518	voxels	_
46-30	7519-7521	in	_
46-31	7522-7525	the	_
46-32	7526-7530	mask	_
46-33	7531-7535	that	_
46-34	7536-7542	showed	_
46-35	7543-7547	even	_
46-36	7548-7552	weak	_
46-37	7553-7566	relationships	_
46-38	7567-7571	with	_
46-39	7572-7575	the	_
46-40	7576-7580	task	_
46-41	7581-7591	regressors	_
46-42	7592-7593	(	_
46-43	7594-7595	p	_
46-44	7596-7597	<	_
46-45	7598-7601	0.2	_
46-46	7602-7603	)	_
46-47	7604-7608	were	_
46-48	7609-7617	excluded	_
46-49	7618-7619	.	_

Text=Time series data for the remaining voxels in the noise ROI mask were then subjected to a PCA, and a number of noise (principal) components comprising weighted averages of white matter and CSF voxel time series were extracted.
47-1	7620-7624	Time	_
47-2	7625-7631	series	_
47-3	7632-7636	data	_
47-4	7637-7640	for	_
47-5	7641-7644	the	_
47-6	7645-7654	remaining	_
47-7	7655-7661	voxels	_
47-8	7662-7664	in	_
47-9	7665-7668	the	_
47-10	7669-7674	noise	_
47-11	7675-7678	ROI	_
47-12	7679-7683	mask	_
47-13	7684-7688	were	_
47-14	7689-7693	then	_
47-15	7694-7703	subjected	_
47-16	7704-7706	to	_
47-17	7707-7708	a	_
47-18	7709-7712	PCA	_
47-19	7713-7714	,	_
47-20	7715-7718	and	_
47-21	7719-7720	a	_
47-22	7721-7727	number	_
47-23	7728-7730	of	_
47-24	7731-7736	noise	_
47-25	7737-7738	(	_
47-26	7739-7748	principal	_
47-27	7749-7750	)	_
47-28	7751-7761	components	_
47-29	7762-7772	comprising	_
47-30	7773-7781	weighted	_
47-31	7782-7790	averages	_
47-32	7791-7793	of	_
47-33	7794-7799	white	_
47-34	7800-7806	matter	_
47-35	7807-7810	and	_
47-36	7811-7814	CSF	_
47-37	7815-7820	voxel	_
47-38	7821-7825	time	_
47-39	7826-7832	series	_
47-40	7833-7837	were	_
47-41	7838-7847	extracted	_
47-42	7848-7849	.	_

Text=The number of components extracted was determined for each subject using a version of the broken stick method, a bootstrap procedure.
48-1	7850-7853	The	_
48-2	7854-7860	number	_
48-3	7861-7863	of	_
48-4	7864-7874	components	_
48-5	7875-7884	extracted	_
48-6	7885-7888	was	_
48-7	7889-7899	determined	_
48-8	7900-7903	for	_
48-9	7904-7908	each	_
48-10	7909-7916	subject	_
48-11	7917-7922	using	_
48-12	7923-7924	a	_
48-13	7925-7932	version	_
48-14	7933-7935	of	_
48-15	7936-7939	the	_
48-16	7940-7946	broken	_
48-17	7947-7952	stick	_
48-18	7953-7959	method	_
48-19	7960-7961	,	_
48-20	7962-7963	a	_
48-21	7964-7973	bootstrap	_
48-22	7974-7983	procedure	_
48-23	7984-7985	.	_

Text=For individual participant (first-level) modeling of the fMRI data, an event-related analysis was implemented.
49-1	7986-7989	For	_
49-2	7990-8000	individual	_
49-3	8001-8012	participant	_
49-4	8013-8014	(	_
49-5	8015-8026	first-level	_
49-6	8027-8028	)	_
49-7	8029-8037	modeling	_
49-8	8038-8040	of	_
49-9	8041-8044	the	_
49-10	8045-8049	fMRI	_
49-11	8050-8054	data	_
49-12	8055-8056	,	_
49-13	8057-8059	an	_
49-14	8060-8073	event-related	_
49-15	8074-8082	analysis	_
49-16	8083-8086	was	_
49-17	8087-8098	implemented	_
49-18	8099-8100	.	_

Text=SPM's canonical hemodynamic response function (a double gamma function) was convolved with task event vectors to create a first-level task regressor representing the predicted response of a voxel activated by the presented tones.
50-1	8101-8104	SPM	_
50-2	8105-8107	's	_
50-3	8108-8117	canonical	_
50-4	8118-8129	hemodynamic	_
50-5	8130-8138	response	_
50-6	8139-8147	function	_
50-7	8148-8149	(	_
50-8	8150-8151	a	_
50-9	8152-8158	double	_
50-10	8159-8164	gamma	_
50-11	8165-8173	function	_
50-12	8174-8175	)	_
50-13	8176-8179	was	_
50-14	8180-8189	convolved	_
50-15	8190-8194	with	_
50-16	8195-8199	task	_
50-17	8200-8205	event	_
50-18	8206-8213	vectors	_
50-19	8214-8216	to	_
50-20	8217-8223	create	_
50-21	8224-8225	a	_
50-22	8226-8237	first-level	_
50-23	8238-8242	task	_
50-24	8243-8252	regressor	_
50-25	8253-8265	representing	_
50-26	8266-8269	the	_
50-27	8270-8279	predicted	_
50-28	8280-8288	response	_
50-29	8289-8291	of	_
50-30	8292-8293	a	_
50-31	8294-8299	voxel	_
50-32	8300-8309	activated	_
50-33	8310-8312	by	_
50-34	8313-8316	the	_
50-35	8317-8326	presented	_
50-36	8327-8332	tones	_
50-37	8333-8334	.	_

Text=After applying a high pass temporal filter (128 s cut-off) to remove low-frequency noise, a general linear model was implemented voxel-wise, regressing each voxel's time series on the task regressor, as well as on nuisance regressors consisting of the aCompCor noise components.
51-1	8335-8340	After	_
51-2	8341-8349	applying	_
51-3	8350-8351	a	_
51-4	8352-8356	high	_
51-5	8357-8361	pass	_
51-6	8362-8370	temporal	_
51-7	8371-8377	filter	_
51-8	8378-8379	(	_
51-9	8380-8383	128	_
51-10	8384-8385	s	_
51-11	8386-8393	cut-off	_
51-12	8394-8395	)	_
51-13	8396-8398	to	_
51-14	8399-8405	remove	_
51-15	8406-8419	low-frequency	_
51-16	8420-8425	noise	_
51-17	8426-8427	,	_
51-18	8428-8429	a	_
51-19	8430-8437	general	_
51-20	8438-8444	linear	_
51-21	8445-8450	model	_
51-22	8451-8454	was	_
51-23	8455-8466	implemented	_
51-24	8467-8477	voxel-wise	_
51-25	8478-8479	,	_
51-26	8480-8490	regressing	_
51-27	8491-8495	each	_
51-28	8496-8501	voxel	_
51-29	8502-8504	's	_
51-30	8505-8509	time	_
51-31	8510-8516	series	_
51-32	8517-8519	on	_
51-33	8520-8523	the	_
51-34	8524-8528	task	_
51-35	8529-8538	regressor	_
51-36	8539-8540	,	_
51-37	8541-8543	as	_
51-38	8544-8548	well	_
51-39	8549-8551	as	_
51-40	8552-8554	on	_
51-41	8555-8563	nuisance	_
51-42	8564-8574	regressors	_
51-43	8575-8585	consisting	_
51-44	8586-8588	of	_
51-45	8589-8592	the	_
51-46	8593-8601	aCompCor	_
51-47	8602-8607	noise	_
51-48	8608-8618	components	_
51-49	8619-8620	.	_

Text=Parameters (i.e.
52-1	8621-8631	Parameters	_
52-2	8632-8633	(	_
52-3	8634-8637	i.e	_
52-4	8638-8639	.	_

Text=beta coefficients) representing the fit of the task regressor to a voxel's time series were estimated, and resulting beta images, reflecting the contrast of tones versus implicit baseline (rest blocks), were then averaged over the two task runs.
53-1	8640-8644	beta	_
53-2	8645-8657	coefficients	_
53-3	8658-8659	)	_
53-4	8660-8672	representing	_
53-5	8673-8676	the	_
53-6	8677-8680	fit	_
53-7	8681-8683	of	_
53-8	8684-8687	the	_
53-9	8688-8692	task	_
53-10	8693-8702	regressor	_
53-11	8703-8705	to	_
53-12	8706-8707	a	_
53-13	8708-8713	voxel	_
53-14	8714-8716	's	_
53-15	8717-8721	time	_
53-16	8722-8728	series	_
53-17	8729-8733	were	_
53-18	8734-8743	estimated	_
53-19	8744-8745	,	_
53-20	8746-8749	and	_
53-21	8750-8759	resulting	_
53-22	8760-8764	beta	_
53-23	8765-8771	images	_
53-24	8772-8773	,	_
53-25	8774-8784	reflecting	_
53-26	8785-8788	the	_
53-27	8789-8797	contrast	_
53-28	8798-8800	of	_
53-29	8801-8806	tones	_
53-30	8807-8813	versus	_
53-31	8814-8822	implicit	_
53-32	8823-8831	baseline	_
53-33	8832-8833	(	_
53-34	8834-8838	rest	_
53-35	8839-8845	blocks	_
53-36	8846-8847	)	_
53-37	8848-8849	,	_
53-38	8850-8854	were	_
53-39	8855-8859	then	_
53-40	8860-8868	averaged	_
53-41	8869-8873	over	_
53-42	8874-8877	the	_
53-43	8878-8881	two	_
53-44	8882-8886	task	_
53-45	8887-8891	runs	_
53-46	8892-8893	.	_

Text=Next, mean beta images were normalized by applying the spatial transformation matrix derived from normalization of the mean functional image (generated during motion correction) to the Montreal Neurological Institute's EPI template (http: //www.bic.mni.mcgill.ca).
54-1	8894-8898	Next	_
54-2	8899-8900	,	_
54-3	8901-8905	mean	_
54-4	8906-8910	beta	_
54-5	8911-8917	images	_
54-6	8918-8922	were	_
54-7	8923-8933	normalized	_
54-8	8934-8936	by	_
54-9	8937-8945	applying	_
54-10	8946-8949	the	_
54-11	8950-8957	spatial	_
54-12	8958-8972	transformation	_
54-13	8973-8979	matrix	_
54-14	8980-8987	derived	_
54-15	8988-8992	from	_
54-16	8993-9006	normalization	_
54-17	9007-9009	of	_
54-18	9010-9013	the	_
54-19	9014-9018	mean	_
54-20	9019-9029	functional	_
54-21	9030-9035	image	_
54-22	9036-9037	(	_
54-23	9038-9047	generated	_
54-24	9048-9054	during	_
54-25	9055-9061	motion	_
54-26	9062-9072	correction	_
54-27	9073-9074	)	_
54-28	9075-9077	to	_
54-29	9078-9081	the	_
54-30	9082-9090	Montreal	_
54-31	9091-9103	Neurological	_
54-32	9104-9113	Institute	_
54-33	9114-9116	's	_
54-34	9117-9120	EPI	_
54-35	9121-9129	template	_
54-36	9130-9131	(	_
54-37	9132-9136	http	_
54-38	9137-9138	:	_
54-39	9139-9162	//www.bic.mni.mcgill.ca	_
54-40	9163-9164	)	_
54-41	9165-9166	.	_

Text=Normalized beta images were resliced to 3 mm3 isotropic voxel dimensions using a fourth degree B-spline and were then spatially smoothed with a 6 mm full-width-half-maximum Gaussian kernel.
55-1	9167-9177	Normalized	_
55-2	9178-9182	beta	_
55-3	9183-9189	images	_
55-4	9190-9194	were	_
55-5	9195-9203	resliced	_
55-6	9204-9206	to	_
55-7	9207-9208	3	_
55-8	9209-9212	mm3	_
55-9	9213-9222	isotropic	_
55-10	9223-9228	voxel	_
55-11	9229-9239	dimensions	_
55-12	9240-9245	using	_
55-13	9246-9247	a	_
55-14	9248-9254	fourth	_
55-15	9255-9261	degree	_
55-16	9262-9270	B-spline	_
55-17	9271-9274	and	_
55-18	9275-9279	were	_
55-19	9280-9284	then	_
55-20	9285-9294	spatially	_
55-21	9295-9303	smoothed	_
55-22	9304-9308	with	_
55-23	9309-9310	a	_
55-24	9311-9312	6	_
55-25	9313-9315	mm	_
55-26	9316-9339	full-width-half-maximum	_
55-27	9340-9348	Gaussian	_
55-28	9349-9355	kernel	_
55-29	9356-9357	.	_

Text=Subsequently, each subject's first-level analysis brain mask image was normalized and applied to the smoothed beta image to mask out regions with insufficient signal intensity, as determined by SPM during first level modeling.
56-1	9358-9370	Subsequently	_
56-2	9371-9372	,	_
56-3	9373-9377	each	_
56-4	9378-9385	subject	_
56-5	9386-9388	's	_
56-6	9389-9400	first-level	_
56-7	9401-9409	analysis	_
56-8	9410-9415	brain	_
56-9	9416-9420	mask	_
56-10	9421-9426	image	_
56-11	9427-9430	was	_
56-12	9431-9441	normalized	_
56-13	9442-9445	and	_
56-14	9446-9453	applied	_
56-15	9454-9456	to	_
56-16	9457-9460	the	_
56-17	9461-9469	smoothed	_
56-18	9470-9474	beta	_
56-19	9475-9480	image	_
56-20	9481-9483	to	_
56-21	9484-9488	mask	_
56-22	9489-9492	out	_
56-23	9493-9500	regions	_
56-24	9501-9505	with	_
56-25	9506-9518	insufficient	_
56-26	9519-9525	signal	_
56-27	9526-9535	intensity	_
56-28	9536-9537	,	_
56-29	9538-9540	as	_
56-30	9541-9551	determined	_
56-31	9552-9554	by	_
56-32	9555-9558	SPM	_
56-33	9559-9565	during	_
56-34	9566-9571	first	_
56-35	9572-9577	level	_
56-36	9578-9586	modeling	_
56-37	9587-9588	.	_

Text=In addition, a ventricular mask, generated using the Talairach Daemon database in Wake Forrest University's Pick Atlas, was used to mask out the lateral ventricles in the single subject normalized smoothed beta images.
57-1	9589-9591	In	_
57-2	9592-9600	addition	_
57-3	9601-9602	,	_
57-4	9603-9604	a	_
57-5	9605-9616	ventricular	_
57-6	9617-9621	mask	_
57-7	9622-9623	,	_
57-8	9624-9633	generated	_
57-9	9634-9639	using	_
57-10	9640-9643	the	_
57-11	9644-9653	Talairach	_
57-12	9654-9660	Daemon	_
57-13	9661-9669	database	_
57-14	9670-9672	in	_
57-15	9673-9677	Wake	_
57-16	9678-9685	Forrest	_
57-17	9686-9696	University	_
57-18	9697-9699	's	_
57-19	9700-9704	Pick	_
57-20	9705-9710	Atlas	_
57-21	9711-9712	,	_
57-22	9713-9716	was	_
57-23	9717-9721	used	_
57-24	9722-9724	to	_
57-25	9725-9729	mask	_
57-26	9730-9733	out	_
57-27	9734-9737	the	_
57-28	9738-9745	lateral	_
57-29	9746-9756	ventricles	_
57-30	9757-9759	in	_
57-31	9760-9763	the	_
57-32	9764-9770	single	_
57-33	9771-9778	subject	_
57-34	9779-9789	normalized	_
57-35	9790-9798	smoothed	_
57-36	9799-9803	beta	_
57-37	9804-9810	images	_
57-38	9811-9812	.	_

Text=EEG data acquisition, preprocessing, and analysis Continuous EEG data were collected from 32 sites using BrainAmp MR plus, with high-input impedance specifically designed for recordings in high magnetic fields (BrainProducts, Munich, Germany).
58-1	9813-9816	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
58-2	9817-9821	data	_
58-3	9822-9833	acquisition	_
58-4	9834-9835	,	_
58-5	9836-9849	preprocessing	_
58-6	9850-9851	,	_
58-7	9852-9855	and	_
58-8	9856-9864	analysis	_
58-9	9865-9875	Continuous	_
58-10	9876-9879	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
58-11	9880-9884	data	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
58-12	9885-9889	were	_
58-13	9890-9899	collected	_
58-14	9900-9904	from	_
58-15	9905-9907	32	_
58-16	9908-9913	sites	_
58-17	9914-9919	using	_
58-18	9920-9928	BrainAmp	_
58-19	9929-9931	MR	_
58-20	9932-9936	plus	_
58-21	9937-9938	,	_
58-22	9939-9943	with	_
58-23	9944-9954	high-input	_
58-24	9955-9964	impedance	_
58-25	9965-9977	specifically	_
58-26	9978-9986	designed	_
58-27	9987-9990	for	_
58-28	9991-10001	recordings	_
58-29	10002-10004	in	_
58-30	10005-10009	high	_
58-31	10010-10018	magnetic	_
58-32	10019-10025	fields	_
58-33	10026-10027	(	_
58-34	10028-10041	BrainProducts	_
58-35	10042-10043	,	_
58-36	10044-10050	Munich	_
58-37	10051-10052	,	_
58-38	10053-10060	Germany	_
58-39	10061-10062	)	_
58-40	10063-10064	.	_

Text=We used sintered Ag/AgCl ring electrodes with 5 kΩ resistors embedded in an electrode cap according to the 10–20 system (Falk Minow Services, Herrsching, Germany).
59-1	10065-10067	We	_
59-2	10068-10072	used	_
59-3	10073-10081	sintered	_
59-4	10082-10089	Ag/AgCl	_
59-5	10090-10094	ring	_
59-6	10095-10105	electrodes	_
59-7	10106-10110	with	_
59-8	10111-10112	5	_
59-9	10113-10115	kΩ	_
59-10	10116-10125	resistors	_
59-11	10126-10134	embedded	_
59-12	10135-10137	in	_
59-13	10138-10140	an	_
59-14	10141-10150	electrode	_
59-15	10151-10154	cap	_
59-16	10155-10164	according	_
59-17	10165-10167	to	_
59-18	10168-10171	the	_
59-19	10172-10177	10–20	_
59-20	10178-10184	system	_
59-21	10185-10186	(	_
59-22	10187-10191	Falk	_
59-23	10192-10197	Minow	_
59-24	10198-10206	Services	_
59-25	10207-10208	,	_
59-26	10209-10219	Herrsching	_
59-27	10220-10221	,	_
59-28	10222-10229	Germany	_
59-29	10230-10231	)	_
59-30	10232-10233	.	_

Text=An electrode was placed on the lower back to monitor electrocardiograms (ECG).
60-1	10234-10236	An	_
60-2	10237-10246	electrode	_
60-3	10247-10250	was	_
60-4	10251-10257	placed	_
60-5	10258-10260	on	_
60-6	10261-10264	the	_
60-7	10265-10270	lower	_
60-8	10271-10275	back	_
60-9	10276-10278	to	_
60-10	10279-10286	monitor	_
60-11	10287-10305	electrocardiograms	_
60-12	10306-10307	(	_
60-13	10308-10311	ECG	_
60-14	10312-10313	)	_
60-15	10314-10315	.	_

Text=Electrode impedances were kept below 10 kΩ.
61-1	10316-10325	Electrode	_
61-2	10326-10336	impedances	_
61-3	10337-10341	were	_
61-4	10342-10346	kept	_
61-5	10347-10352	below	_
61-6	10353-10355	10	_
61-7	10356-10358	kΩ	_
61-8	10359-10360	.	_

Text=The nonmagnetic, battery powered, EEG amplifier was placed behind the MRI head coil and stabilized with sandbags.
62-1	10361-10364	The	_
62-2	10365-10376	nonmagnetic	_
62-3	10377-10378	,	_
62-4	10379-10386	battery	_
62-5	10387-10394	powered	http://maven.renci.org/NeuroBridge/neurobridge#Reference
62-6	10395-10396	,	http://maven.renci.org/NeuroBridge/neurobridge#Reference
62-7	10397-10400	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
62-8	10401-10410	amplifier	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
62-9	10411-10414	was	_
62-10	10415-10421	placed	_
62-11	10422-10428	behind	_
62-12	10429-10432	the	_
62-13	10433-10436	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
62-14	10437-10441	head	_
62-15	10442-10446	coil	_
62-16	10447-10450	and	_
62-17	10451-10461	stabilized	_
62-18	10462-10466	with	_
62-19	10467-10475	sandbags	_
62-20	10476-10477	.	_

Text=The subject's head was immobilized using cushions.
63-1	10478-10481	The	_
63-2	10482-10489	subject	_
63-3	10490-10492	's	_
63-4	10493-10497	head	_
63-5	10498-10501	was	_
63-6	10502-10513	immobilized	_
63-7	10514-10519	using	_
63-8	10520-10528	cushions	_
63-9	10529-10530	.	_

Text=EEG data were transmitted via a fiber optic cable to a BrainAmp USB Adapter that synchronized the EEG acquisition clock to the MRI master clock via a SyncBox (BrainProducts) before transferring data via USB to a laptop computer placed outside the scanner room.
64-1	10531-10534	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
64-2	10535-10539	data	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
64-3	10540-10544	were	_
64-4	10545-10556	transmitted	_
64-5	10557-10560	via	_
64-6	10561-10562	a	_
64-7	10563-10568	fiber	_
64-8	10569-10574	optic	_
64-9	10575-10580	cable	_
64-10	10581-10583	to	_
64-11	10584-10585	a	_
64-12	10586-10594	BrainAmp	_
64-13	10595-10598	USB	_
64-14	10599-10606	Adapter	_
64-15	10607-10611	that	_
64-16	10612-10624	synchronized	_
64-17	10625-10628	the	_
64-18	10629-10632	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
64-19	10633-10644	acquisition	_
64-20	10645-10650	clock	_
64-21	10651-10653	to	_
64-22	10654-10657	the	_
64-23	10658-10661	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
64-24	10662-10668	master	_
64-25	10669-10674	clock	_
64-26	10675-10678	via	_
64-27	10679-10680	a	_
64-28	10681-10688	SyncBox	_
64-29	10689-10690	(	_
64-30	10691-10704	BrainProducts	_
64-31	10705-10706	)	_
64-32	10707-10713	before	_
64-33	10714-10726	transferring	_
64-34	10727-10731	data	_
64-35	10732-10735	via	_
64-36	10736-10739	USB	_
64-37	10740-10742	to	_
64-38	10743-10744	a	_
64-39	10745-10751	laptop	_
64-40	10752-10760	computer	_
64-41	10761-10767	placed	_
64-42	10768-10775	outside	_
64-43	10776-10779	the	_
64-44	10780-10787	scanner	_
64-45	10788-10792	room	_
64-46	10793-10794	.	_

Text=All 32 channels were recorded with FCz as reference and AFz as ground to minimize the distance between reference and recording sites and to prevent amplifier saturation.
65-1	10795-10798	All	_
65-2	10799-10801	32	_
65-3	10802-10810	channels	_
65-4	10811-10815	were	_
65-5	10816-10824	recorded	_
65-6	10825-10829	with	_
65-7	10830-10833	FCz	_
65-8	10834-10836	as	_
65-9	10837-10846	reference	_
65-10	10847-10850	and	_
65-11	10851-10854	AFz	_
65-12	10855-10857	as	_
65-13	10858-10864	ground	_
65-14	10865-10867	to	_
65-15	10868-10876	minimize	_
65-16	10877-10880	the	_
65-17	10881-10889	distance	_
65-18	10890-10897	between	_
65-19	10898-10907	reference	_
65-20	10908-10911	and	_
65-21	10912-10921	recording	_
65-22	10922-10927	sites	_
65-23	10928-10931	and	_
65-24	10932-10934	to	_
65-25	10935-10942	prevent	_
65-26	10943-10952	amplifier	_
65-27	10953-10963	saturation	_
65-28	10964-10965	.	_

Text=The data were recorded with a bandpass filter of 0.01–250 Hz and digitized at a rate of 5 kHz with 0.5 μV resolution (16 bit dynamic range, 16.38 mV).
66-1	10966-10969	The	_
66-2	10970-10974	data	_
66-3	10975-10979	were	_
66-4	10980-10988	recorded	_
66-5	10989-10993	with	_
66-6	10994-10995	a	_
66-7	10996-11004	bandpass	_
66-8	11005-11011	filter	_
66-9	11012-11014	of	_
66-10	11015-11023	0.01–250	_
66-11	11024-11026	Hz	_
66-12	11027-11030	and	_
66-13	11031-11040	digitized	_
66-14	11041-11043	at	_
66-15	11044-11045	a	_
66-16	11046-11050	rate	_
66-17	11051-11053	of	_
66-18	11054-11055	5	_
66-19	11056-11059	kHz	_
66-20	11060-11064	with	_
66-21	11065-11068	0.5	_
66-22	11069-11071	μV	_
66-23	11072-11082	resolution	_
66-24	11083-11084	(	_
66-25	11085-11087	16	_
66-26	11088-11091	bit	_
66-27	11092-11099	dynamic	_
66-28	11100-11105	range	_
66-29	11106-11107	,	_
66-30	11108-11113	16.38	_
66-31	11114-11116	mV	_
66-32	11117-11118	)	_
66-33	11119-11120	.	_

Text=Removal of artifacts from EEG EEG data were corrected for MR gradient artifacts by applying modified algorithms proposed by as implemented in Brain Vision Analyzer 2.0.4.368 software (BrainProducts).
67-1	11121-11128	Removal	_
67-2	11129-11131	of	_
67-3	11132-11141	artifacts	_
67-4	11142-11146	from	_
67-5	11147-11150	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
67-6	11151-11154	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
67-7	11155-11159	data	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
67-8	11160-11164	were	_
67-9	11165-11174	corrected	_
67-10	11175-11178	for	_
67-11	11179-11181	MR	_
67-12	11182-11190	gradient	_
67-13	11191-11200	artifacts	_
67-14	11201-11203	by	_
67-15	11204-11212	applying	_
67-16	11213-11221	modified	_
67-17	11222-11232	algorithms	_
67-18	11233-11241	proposed	_
67-19	11242-11244	by	_
67-20	11245-11247	as	_
67-21	11248-11259	implemented	_
67-22	11260-11262	in	_
67-23	11263-11268	Brain	_
67-24	11269-11275	Vision	_
67-25	11276-11284	Analyzer	_
67-26	11285-11294	2.0.4.368	_
67-27	11295-11303	software	_
67-28	11304-11305	(	_
67-29	11306-11319	BrainProducts	_
67-30	11320-11321	)	_
67-31	11322-11323	.	_

Text=Next, the ECG channel was bandpass filtered 1–20 Hz to facilitate heartbeat detection and subsequent ballistocardiac artifact correction (see Appendix A for details.)
68-1	11324-11328	Next	_
68-2	11329-11330	,	_
68-3	11331-11334	the	_
68-4	11335-11338	ECG	_
68-5	11339-11346	channel	_
68-6	11347-11350	was	_
68-7	11351-11359	bandpass	_
68-8	11360-11368	filtered	_
68-9	11369-11373	1–20	_
68-10	11374-11376	Hz	_
68-11	11377-11379	to	_
68-12	11380-11390	facilitate	_
68-13	11391-11400	heartbeat	_
68-14	11401-11410	detection	_
68-15	11411-11414	and	_
68-16	11415-11425	subsequent	_
68-17	11426-11441	ballistocardiac	_
68-18	11442-11450	artifact	_
68-19	11451-11461	correction	_
68-20	11462-11463	(	_
68-21	11464-11467	see	_
68-22	11468-11476	Appendix	_
68-23	11477-11478	A	_
68-24	11479-11482	for	_
68-25	11483-11490	details	_
68-26	11491-11492	.	_
68-27	11493-11494	)	_

Text=Canonical correlation-based denoising of EEG Canonical correlation analysis (CCA) was used as a blind source separation technique to remove broadband or electromyography (EMG) noise from single trial EEG data using a method similar to that used by others with some important differences.
69-1	11495-11504	Canonical	_
69-2	11505-11522	correlation-based	_
69-3	11523-11532	denoising	_
69-4	11533-11535	of	_
69-5	11536-11539	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
69-6	11540-11549	Canonical	_
69-7	11550-11561	correlation	_
69-8	11562-11570	analysis	_
69-9	11571-11572	(	_
69-10	11573-11576	CCA	_
69-11	11577-11578	)	_
69-12	11579-11582	was	_
69-13	11583-11587	used	_
69-14	11588-11590	as	_
69-15	11591-11592	a	_
69-16	11593-11598	blind	_
69-17	11599-11605	source	_
69-18	11606-11616	separation	_
69-19	11617-11626	technique	_
69-20	11627-11629	to	_
69-21	11630-11636	remove	_
69-22	11637-11646	broadband	_
69-23	11647-11649	or	_
69-24	11650-11666	electromyography	_
69-25	11667-11668	(	_
69-26	11669-11672	EMG	_
69-27	11673-11674	)	_
69-28	11675-11680	noise	_
69-29	11681-11685	from	_
69-30	11686-11692	single	_
69-31	11693-11698	trial	_
69-32	11699-11702	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
69-33	11703-11707	data	_
69-34	11708-11713	using	_
69-35	11714-11715	a	_
69-36	11716-11722	method	_
69-37	11723-11730	similar	_
69-38	11731-11733	to	_
69-39	11734-11738	that	_
69-40	11739-11743	used	_
69-41	11744-11746	by	_
69-42	11747-11753	others	_
69-43	11754-11758	with	_
69-44	11759-11763	some	_
69-45	11764-11773	important	_
69-46	11774-11785	differences	_
69-47	11786-11787	.	_

Text=The CCA de-noising procedure involves correlating time series data from all channels with the one-sample time-lagged series from all channels, which is the multivariate equivalent of auto-regressive time series correlation.
70-1	11788-11791	The	_
70-2	11792-11795	CCA	_
70-3	11796-11806	de-noising	_
70-4	11807-11816	procedure	_
70-5	11817-11825	involves	_
70-6	11826-11837	correlating	_
70-7	11838-11842	time	_
70-8	11843-11849	series	_
70-9	11850-11854	data	_
70-10	11855-11859	from	_
70-11	11860-11863	all	_
70-12	11864-11872	channels	_
70-13	11873-11877	with	_
70-14	11878-11881	the	_
70-15	11882-11892	one-sample	_
70-16	11893-11904	time-lagged	_
70-17	11905-11911	series	_
70-18	11912-11916	from	_
70-19	11917-11920	all	_
70-20	11921-11929	channels	_
70-21	11930-11931	,	_
70-22	11932-11937	which	_
70-23	11938-11940	is	_
70-24	11941-11944	the	_
70-25	11945-11957	multivariate	_
70-26	11958-11968	equivalent	_
70-27	11969-11971	of	_
70-28	11972-11987	auto-regressive	_
70-29	11988-11992	time	_
70-30	11993-11999	series	_
70-31	12000-12011	correlation	_
70-32	12012-12013	.	_

Text=Each set of canonical correlation coefficients (one for each scalp electrode resulting in 31 for this study) has an associated time series (i.e.
71-1	12014-12018	Each	_
71-2	12019-12022	set	_
71-3	12023-12025	of	_
71-4	12026-12035	canonical	_
71-5	12036-12047	correlation	_
71-6	12048-12060	coefficients	_
71-7	12061-12062	(	_
71-8	12063-12066	one	_
71-9	12067-12070	for	_
71-10	12071-12075	each	_
71-11	12076-12081	scalp	_
71-12	12082-12091	electrode	_
71-13	12092-12101	resulting	_
71-14	12102-12104	in	_
71-15	12105-12107	31	_
71-16	12108-12111	for	_
71-17	12112-12116	this	_
71-18	12117-12122	study	_
71-19	12123-12124	)	_
71-20	12125-12128	has	_
71-21	12129-12131	an	_
71-22	12132-12142	associated	_
71-23	12143-12147	time	_
71-24	12148-12154	series	_
71-25	12155-12156	(	_
71-26	12157-12160	i.e	_
71-27	12161-12162	.	_

Text=linear function of the coefficients and raw data called canonical variates).
72-1	12163-12169	linear	_
72-2	12170-12178	function	_
72-3	12179-12181	of	_
72-4	12182-12185	the	_
72-5	12186-12198	coefficients	_
72-6	12199-12202	and	_
72-7	12203-12206	raw	_
72-8	12207-12211	data	_
72-9	12212-12218	called	_
72-10	12219-12228	canonical	_
72-11	12229-12237	variates	_
72-12	12238-12239	)	_
72-13	12240-12241	.	_

Text=The fast Fourier transformed (FFT) power spectra of these canonical variate time series have been used to identify EMG components by taking the ratio of high (e.g.
73-1	12242-12245	The	_
73-2	12246-12250	fast	_
73-3	12251-12258	Fourier	_
73-4	12259-12270	transformed	_
73-5	12271-12272	(	_
73-6	12273-12276	FFT	_
73-7	12277-12278	)	_
73-8	12279-12284	power	_
73-9	12285-12292	spectra	_
73-10	12293-12295	of	_
73-11	12296-12301	these	_
73-12	12302-12311	canonical	_
73-13	12312-12319	variate	_
73-14	12320-12324	time	_
73-15	12325-12331	series	_
73-16	12332-12336	have	_
73-17	12337-12341	been	_
73-18	12342-12346	used	_
73-19	12347-12349	to	_
73-20	12350-12358	identify	_
73-21	12359-12362	EMG	_
73-22	12363-12373	components	_
73-23	12374-12376	by	_
73-24	12377-12383	taking	_
73-25	12384-12387	the	_
73-26	12388-12393	ratio	_
73-27	12394-12396	of	_
73-28	12397-12401	high	_
73-29	12402-12403	(	_
73-30	12404-12407	e.g	_
73-31	12408-12409	.	_

Text=15 to 30 Hz) to low (e.g.
74-1	12410-12412	15	_
74-2	12413-12415	to	_
74-3	12416-12418	30	_
74-4	12419-12421	Hz	_
74-5	12422-12423	)	_
74-6	12424-12426	to	_
74-7	12427-12430	low	_
74-8	12431-12432	(	_
74-9	12433-12436	e.g	_
74-10	12437-12438	.	_

Text=<15 Hz) power and removing components with ratios greater than a pre-determined limit (e.g.
75-1	12439-12440	<	_
75-2	12441-12443	15	_
75-3	12444-12446	Hz	_
75-4	12447-12448	)	_
75-5	12449-12454	power	_
75-6	12455-12458	and	_
75-7	12459-12467	removing	_
75-8	12468-12478	components	_
75-9	12479-12483	with	_
75-10	12484-12490	ratios	_
75-11	12491-12498	greater	_
75-12	12499-12503	than	_
75-13	12504-12505	a	_
75-14	12506-12520	pre-determined	_
75-15	12521-12526	limit	_
75-16	12527-12528	(	_
75-17	12529-12532	e.g	_
75-18	12533-12534	.	_

Text=if high/low> 1/5 in).
76-1	12535-12537	if	_
76-2	12538-12546	high/low	_
76-3	12547-12548	>	_
76-4	12549-12552	1/5	_
76-5	12553-12555	in	_
76-6	12556-12557	)	_
76-7	12558-12559	.	_

Text=This is a very rough heuristic for determining if a canonical variate's power spectrum has power-law scaling (e.g.
77-1	12560-12564	This	_
77-2	12565-12567	is	_
77-3	12568-12569	a	_
77-4	12570-12574	very	_
77-5	12575-12580	rough	_
77-6	12581-12590	heuristic	_
77-7	12591-12594	for	_
77-8	12595-12606	determining	_
77-9	12607-12609	if	_
77-10	12610-12611	a	_
77-11	12612-12621	canonical	_
77-12	12622-12629	variate	_
77-13	12630-12632	's	_
77-14	12633-12638	power	_
77-15	12639-12647	spectrum	_
77-16	12648-12651	has	_
77-17	12652-12661	power-law	_
77-18	12662-12669	scaling	_
77-19	12670-12671	(	_
77-20	12672-12675	e.g	_
77-21	12676-12677	.	_

Text=1/fβ or fα, where − β = α) where log-transformed power decreases linearly with increasing log-transformed frequency.
78-1	12678-12682	1/fβ	_
78-2	12683-12685	or	_
78-3	12686-12688	fα	_
78-4	12689-12690	,	_
78-5	12691-12696	where	_
78-6	12697-12698	−	_
78-7	12699-12700	β	_
78-8	12701-12702	=	_
78-9	12703-12704	α	_
78-10	12705-12706	)	_
78-11	12707-12712	where	_
78-12	12713-12728	log-transformed	_
78-13	12729-12734	power	_
78-14	12735-12744	decreases	_
78-15	12745-12753	linearly	_
78-16	12754-12758	with	_
78-17	12759-12769	increasing	_
78-18	12770-12785	log-transformed	_
78-19	12786-12795	frequency	_
78-20	12796-12797	.	_

Text=Previous studies have suggested that the exponent, α, is less than − 1 in human EEG, while white noise or EMG would have an exponent of approximately zero.
79-1	12798-12806	Previous	_
79-2	12807-12814	studies	_
79-3	12815-12819	have	_
79-4	12820-12829	suggested	_
79-5	12830-12834	that	_
79-6	12835-12838	the	_
79-7	12839-12847	exponent	_
79-8	12848-12849	,	_
79-9	12850-12851	α	_
79-10	12852-12853	,	_
79-11	12854-12856	is	_
79-12	12857-12861	less	_
79-13	12862-12866	than	_
79-14	12867-12868	−	_
79-15	12869-12870	1	_
79-16	12871-12873	in	_
79-17	12874-12879	human	_
79-18	12880-12883	EEG	_
79-19	12884-12885	,	_
79-20	12886-12891	while	_
79-21	12892-12897	white	_
79-22	12898-12903	noise	_
79-23	12904-12906	or	_
79-24	12907-12910	EMG	_
79-25	12911-12916	would	_
79-26	12917-12921	have	_
79-27	12922-12924	an	_
79-28	12925-12933	exponent	_
79-29	12934-12936	of	_
79-30	12937-12950	approximately	_
79-31	12951-12955	zero	_
79-32	12956-12957	.	_

Text=Using simple linear regression, we estimated α by predicting log-power with log-frequency.
80-1	12958-12963	Using	_
80-2	12964-12970	simple	_
80-3	12971-12977	linear	_
80-4	12978-12988	regression	_
80-5	12989-12990	,	_
80-6	12991-12993	we	_
80-7	12994-13003	estimated	_
80-8	13004-13005	α	_
80-9	13006-13008	by	_
80-10	13009-13019	predicting	_
80-11	13020-13029	log-power	_
80-12	13030-13034	with	_
80-13	13035-13048	log-frequency	_
80-14	13049-13050	.	_

Text=For each trial and canonical variate, a bootstrap confidence interval was constructed for the estimated α by randomly sampling, without replacement, half of the frequency bins between 1 and 125 Hz from the FFT one thousand times to avoid potential contamination by a few frequencies (i.e.
81-1	13051-13054	For	_
81-2	13055-13059	each	_
81-3	13060-13065	trial	_
81-4	13066-13069	and	_
81-5	13070-13079	canonical	_
81-6	13080-13087	variate	_
81-7	13088-13089	,	_
81-8	13090-13091	a	_
81-9	13092-13101	bootstrap	_
81-10	13102-13112	confidence	_
81-11	13113-13121	interval	_
81-12	13122-13125	was	_
81-13	13126-13137	constructed	_
81-14	13138-13141	for	_
81-15	13142-13145	the	_
81-16	13146-13155	estimated	_
81-17	13156-13157	α	_
81-18	13158-13160	by	_
81-19	13161-13169	randomly	_
81-20	13170-13178	sampling	_
81-21	13179-13180	,	_
81-22	13181-13188	without	_
81-23	13189-13200	replacement	_
81-24	13201-13202	,	_
81-25	13203-13207	half	_
81-26	13208-13210	of	_
81-27	13211-13214	the	_
81-28	13215-13224	frequency	_
81-29	13225-13229	bins	_
81-30	13230-13237	between	_
81-31	13238-13239	1	_
81-32	13240-13243	and	_
81-33	13244-13247	125	_
81-34	13248-13250	Hz	_
81-35	13251-13255	from	_
81-36	13256-13259	the	_
81-37	13260-13263	FFT	_
81-38	13264-13267	one	_
81-39	13268-13276	thousand	_
81-40	13277-13282	times	_
81-41	13283-13285	to	_
81-42	13286-13291	avoid	_
81-43	13292-13301	potential	_
81-44	13302-13315	contamination	_
81-45	13316-13318	by	_
81-46	13319-13320	a	_
81-47	13321-13324	few	_
81-48	13325-13336	frequencies	_
81-49	13337-13338	(	_
81-50	13339-13342	i.e	_
81-51	13343-13344	.	_

Text=60 Hz or alpha-band).
82-1	13345-13347	60	_
82-2	13348-13350	Hz	_
82-3	13351-13353	or	_
82-4	13354-13364	alpha-band	_
82-5	13365-13366	)	_
82-6	13367-13368	.	_

Text=If the interval contained values less than − 1, the component was retained while all others were algebraically removed during back-projection to the original EEG epoch space (see Appendix A for details.)
83-1	13369-13371	If	_
83-2	13372-13375	the	_
83-3	13376-13384	interval	_
83-4	13385-13394	contained	_
83-5	13395-13401	values	_
83-6	13402-13406	less	_
83-7	13407-13411	than	_
83-8	13412-13413	−	_
83-9	13414-13415	1	_
83-10	13416-13417	,	_
83-11	13418-13421	the	_
83-12	13422-13431	component	_
83-13	13432-13435	was	_
83-14	13436-13444	retained	_
83-15	13445-13450	while	_
83-16	13451-13454	all	_
83-17	13455-13461	others	_
83-18	13462-13466	were	_
83-19	13467-13480	algebraically	_
83-20	13481-13488	removed	_
83-21	13489-13495	during	_
83-22	13496-13511	back-projection	_
83-23	13512-13514	to	_
83-24	13515-13518	the	_
83-25	13519-13527	original	_
83-26	13528-13531	EEG	_
83-27	13532-13537	epoch	_
83-28	13538-13543	space	_
83-29	13544-13545	(	_
83-30	13546-13549	see	_
83-31	13550-13558	Appendix	_
83-32	13559-13560	A	_
83-33	13561-13564	for	_
83-34	13565-13572	details	_
83-35	13573-13574	.	_
83-36	13575-13576	)	_

Text=Final EEG denoising, artifact removal, and ERP derivation Single trial EEG data were re-referenced to an average reference, and data were obtained for the prior reference channel, FCz.
84-1	13577-13582	Final	_
84-2	13583-13586	EEG	_
84-3	13587-13596	denoising	_
84-4	13597-13598	,	_
84-5	13599-13607	artifact	_
84-6	13608-13615	removal	_
84-7	13616-13617	,	_
84-8	13618-13621	and	_
84-9	13622-13625	ERP	_
84-10	13626-13636	derivation	_
84-11	13637-13643	Single	_
84-12	13644-13649	trial	_
84-13	13650-13653	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
84-14	13654-13658	data	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
84-15	13659-13663	were	_
84-16	13664-13677	re-referenced	_
84-17	13678-13680	to	_
84-18	13681-13683	an	_
84-19	13684-13691	average	_
84-20	13692-13701	reference	_
84-21	13702-13703	,	_
84-22	13704-13707	and	_
84-23	13708-13712	data	_
84-24	13713-13717	were	_
84-25	13718-13726	obtained	_
84-26	13727-13730	for	_
84-27	13731-13734	the	_
84-28	13735-13740	prior	_
84-29	13741-13750	reference	_
84-30	13751-13758	channel	_
84-31	13759-13760	,	_
84-32	13761-13764	FCz	_
84-33	13765-13766	.	_

Text=Shorter, − 100 to 250 ms epochs were created for the final processing steps.
85-1	13767-13774	Shorter	_
85-2	13775-13776	,	_
85-3	13777-13778	−	_
85-4	13779-13782	100	_
85-5	13783-13785	to	_
85-6	13786-13789	250	_
85-7	13790-13792	ms	_
85-8	13793-13799	epochs	_
85-9	13800-13804	were	_
85-10	13805-13812	created	_
85-11	13813-13816	for	_
85-12	13817-13820	the	_
85-13	13821-13826	final	_
85-14	13827-13837	processing	_
85-15	13838-13843	steps	_
85-16	13844-13845	.	_

Text=Outlier trials were rejected based on previously established criteria.
86-1	13846-13853	Outlier	_
86-2	13854-13860	trials	_
86-3	13861-13865	were	_
86-4	13866-13874	rejected	_
86-5	13875-13880	based	_
86-6	13881-13883	on	_
86-7	13884-13894	previously	_
86-8	13895-13906	established	_
86-9	13907-13915	criteria	_
86-10	13916-13917	.	_

Text=Prior to conducting an independent components analysis (ICA) of the EEG data, we initially conducted a principal components analysis (PCA) on the stacked single trial 350 time-point × 32 channel EEG data matrices to reduce the data.
87-1	13918-13923	Prior	_
87-2	13924-13926	to	_
87-3	13927-13937	conducting	_
87-4	13938-13940	an	_
87-5	13941-13952	independent	_
87-6	13953-13963	components	_
87-7	13964-13972	analysis	_
87-8	13973-13974	(	_
87-9	13975-13978	ICA	_
87-10	13979-13980	)	_
87-11	13981-13983	of	_
87-12	13984-13987	the	_
87-13	13988-13991	EEG	_
87-14	13992-13996	data	_
87-15	13997-13998	,	_
87-16	13999-14001	we	_
87-17	14002-14011	initially	_
87-18	14012-14021	conducted	_
87-19	14022-14023	a	_
87-20	14024-14033	principal	_
87-21	14034-14044	components	_
87-22	14045-14053	analysis	_
87-23	14054-14055	(	_
87-24	14056-14059	PCA	_
87-25	14060-14061	)	_
87-26	14062-14064	on	_
87-27	14065-14068	the	_
87-28	14069-14076	stacked	_
87-29	14077-14083	single	_
87-30	14084-14089	trial	_
87-31	14090-14093	350	_
87-32	14094-14104	time-point	_
87-33	14105-14106	×	_
87-34	14107-14109	32	_
87-35	14110-14117	channel	_
87-36	14118-14121	EEG	_
87-37	14122-14126	data	_
87-38	14127-14135	matrices	_
87-39	14136-14138	to	_
87-40	14139-14145	reduce	_
87-41	14146-14149	the	_
87-42	14150-14154	data	_
87-43	14155-14156	.	_

Text=The number of principal components to extract was estimated separately for each subject using a parallel test approach.
88-1	14157-14160	The	_
88-2	14161-14167	number	_
88-3	14168-14170	of	_
88-4	14171-14180	principal	_
88-5	14181-14191	components	_
88-6	14192-14194	to	_
88-7	14195-14202	extract	_
88-8	14203-14206	was	_
88-9	14207-14216	estimated	_
88-10	14217-14227	separately	_
88-11	14228-14231	for	_
88-12	14232-14236	each	_
88-13	14237-14244	subject	_
88-14	14245-14250	using	_
88-15	14251-14252	a	_
88-16	14253-14261	parallel	_
88-17	14262-14266	test	_
88-18	14267-14275	approach	_
88-19	14276-14277	.	_

Text=This involved comparing the eigenvalues from the PCA of the stacked, single trial EEG data correlation matrix to eigenvalues from a PCA of a thousand completely simulated random normal data matrices of equal rank.
89-1	14278-14282	This	_
89-2	14283-14291	involved	_
89-3	14292-14301	comparing	_
89-4	14302-14305	the	_
89-5	14306-14317	eigenvalues	_
89-6	14318-14322	from	_
89-7	14323-14326	the	_
89-8	14327-14330	PCA	_
89-9	14331-14333	of	_
89-10	14334-14337	the	_
89-11	14338-14345	stacked	_
89-12	14346-14347	,	_
89-13	14348-14354	single	_
89-14	14355-14360	trial	_
89-15	14361-14364	EEG	_
89-16	14365-14369	data	_
89-17	14370-14381	correlation	_
89-18	14382-14388	matrix	_
89-19	14389-14391	to	_
89-20	14392-14403	eigenvalues	_
89-21	14404-14408	from	_
89-22	14409-14410	a	_
89-23	14411-14414	PCA	_
89-24	14415-14417	of	_
89-25	14418-14419	a	_
89-26	14420-14428	thousand	_
89-27	14429-14439	completely	_
89-28	14440-14449	simulated	_
89-29	14450-14456	random	_
89-30	14457-14463	normal	_
89-31	14464-14468	data	_
89-32	14469-14477	matrices	_
89-33	14478-14480	of	_
89-34	14481-14486	equal	_
89-35	14487-14491	rank	_
89-36	14492-14493	.	_

Text=A 95% cutoff, derived from the simulated data eigenvalue distribution, was used to determine how many components to extract from the EEG data.
90-1	14494-14495	A	_
90-2	14496-14498	95	_
90-3	14499-14500	%	_
90-4	14501-14507	cutoff	_
90-5	14508-14509	,	_
90-6	14510-14517	derived	_
90-7	14518-14522	from	_
90-8	14523-14526	the	_
90-9	14527-14536	simulated	_
90-10	14537-14541	data	_
90-11	14542-14552	eigenvalue	_
90-12	14553-14565	distribution	_
90-13	14566-14567	,	_
90-14	14568-14571	was	_
90-15	14572-14576	used	_
90-16	14577-14579	to	_
90-17	14580-14589	determine	_
90-18	14590-14593	how	_
90-19	14594-14598	many	_
90-20	14599-14609	components	_
90-21	14610-14612	to	_
90-22	14613-14620	extract	_
90-23	14621-14625	from	_
90-24	14626-14629	the	_
90-25	14630-14633	EEG	_
90-26	14634-14638	data	_
90-27	14639-14640	.	_

Text=All subjects had 3, 4, or 5 components with eigenvalues exceeding this cut-off, and neither the number of components (HC: 3.61 ± 0.737, SZ: 3.45 ± 0.602; t (64) = 0.9686, p = 0.3364), nor the percentage of variance explained by those selected components (HC: 91.1 ± 3.7%, SZ: 92.6 ± 2.8%; t (64) = − 1.74, p = 0.0824) significantly differed between groups.
91-1	14641-14644	All	_
91-2	14645-14653	subjects	_
91-3	14654-14657	had	_
91-4	14658-14659	3	_
91-5	14660-14661	,	_
91-6	14662-14663	4	_
91-7	14664-14665	,	_
91-8	14666-14668	or	_
91-9	14669-14670	5	_
91-10	14671-14681	components	_
91-11	14682-14686	with	_
91-12	14687-14698	eigenvalues	_
91-13	14699-14708	exceeding	_
91-14	14709-14713	this	_
91-15	14714-14721	cut-off	_
91-16	14722-14723	,	_
91-17	14724-14727	and	_
91-18	14728-14735	neither	_
91-19	14736-14739	the	_
91-20	14740-14746	number	_
91-21	14747-14749	of	_
91-22	14750-14760	components	_
91-23	14761-14762	(	_
91-24	14763-14765	HC	_
91-25	14766-14767	:	_
91-26	14768-14772	3.61	_
91-27	14773-14774	±	_
91-28	14775-14780	0.737	_
91-29	14781-14782	,	_
91-30	14783-14785	SZ	_
91-31	14786-14787	:	_
91-32	14788-14792	3.45	_
91-33	14793-14794	±	_
91-34	14795-14800	0.602	_
91-35	14801-14802	;	_
91-36	14803-14804	t	_
91-37	14805-14806	(	_
91-38	14807-14809	64	_
91-39	14810-14811	)	_
91-40	14812-14813	=	_
91-41	14814-14820	0.9686	_
91-42	14821-14822	,	_
91-43	14823-14824	p	_
91-44	14825-14826	=	_
91-45	14827-14833	0.3364	_
91-46	14834-14835	)	_
91-47	14836-14837	,	_
91-48	14838-14841	nor	_
91-49	14842-14845	the	_
91-50	14846-14856	percentage	_
91-51	14857-14859	of	_
91-52	14860-14868	variance	_
91-53	14869-14878	explained	_
91-54	14879-14881	by	_
91-55	14882-14887	those	_
91-56	14888-14896	selected	_
91-57	14897-14907	components	_
91-58	14908-14909	(	_
91-59	14910-14912	HC	_
91-60	14913-14914	:	_
91-61	14915-14919	91.1	_
91-62	14920-14921	±	_
91-63	14922-14925	3.7	_
91-64	14926-14927	%	_
91-65	14928-14929	,	_
91-66	14930-14932	SZ	_
91-67	14933-14934	:	_
91-68	14935-14939	92.6	_
91-69	14940-14941	±	_
91-70	14942-14945	2.8	_
91-71	14946-14947	%	_
91-72	14948-14949	;	_
91-73	14950-14951	t	_
91-74	14952-14953	(	_
91-75	14954-14956	64	_
91-76	14957-14958	)	_
91-77	14959-14960	=	_
91-78	14961-14962	−	_
91-79	14963-14967	1.74	_
91-80	14968-14969	,	_
91-81	14970-14971	p	_
91-82	14972-14973	=	_
91-83	14974-14980	0.0824	_
91-84	14981-14982	)	_
91-85	14983-14996	significantly	_
91-86	14997-15005	differed	_
91-87	15006-15013	between	_
91-88	15014-15020	groups	_
91-89	15021-15022	.	_

Text=ICA was then performed on each subject's single trial EEG data in EEGLAB with initial PCA dimension reduction (i.e.
92-1	15023-15026	ICA	_
92-2	15027-15030	was	_
92-3	15031-15035	then	_
92-4	15036-15045	performed	_
92-5	15046-15048	on	_
92-6	15049-15053	each	_
92-7	15054-15061	subject	_
92-8	15062-15064	's	_
92-9	15065-15071	single	_
92-10	15072-15077	trial	_
92-11	15078-15081	EEG	_
92-12	15082-15086	data	_
92-13	15087-15089	in	_
92-14	15090-15096	EEGLAB	_
92-15	15097-15101	with	_
92-16	15102-15109	initial	_
92-17	15110-15113	PCA	_
92-18	15114-15123	dimension	_
92-19	15124-15133	reduction	_
92-20	15134-15135	(	_
92-21	15136-15139	i.e	_
92-22	15140-15141	.	_

Text=number of components to extract from EEG) set according to the previous estimate.
93-1	15142-15148	number	_
93-2	15149-15151	of	_
93-3	15152-15162	components	_
93-4	15163-15165	to	_
93-5	15166-15173	extract	_
93-6	15174-15178	from	_
93-7	15179-15182	EEG	_
93-8	15183-15184	)	_
93-9	15185-15188	set	_
93-10	15189-15198	according	_
93-11	15199-15201	to	_
93-12	15202-15205	the	_
93-13	15206-15214	previous	_
93-14	15215-15223	estimate	_
93-15	15224-15225	.	_

Text=Two researchers independently inspected individual component properties (i.e.
94-1	15226-15229	Two	_
94-2	15230-15241	researchers	_
94-3	15242-15255	independently	_
94-4	15256-15265	inspected	_
94-5	15266-15276	individual	_
94-6	15277-15286	component	_
94-7	15287-15297	properties	_
94-8	15298-15299	(	_
94-9	15300-15303	i.e	_
94-10	15304-15305	.	_

Text=fronto-central N100-P200 spatial loading, auditory evoked potential time course of ERP average from the component's single trial epochs, and 1/f power spectrum) to identify ERP-related independent components (ICs) and to exclude artifact-related ICs, and then they conferred to achieve consensus on which ICs to retain.
95-1	15306-15320	fronto-central	_
95-2	15321-15330	N100-P200	_
95-3	15331-15338	spatial	_
95-4	15339-15346	loading	_
95-5	15347-15348	,	_
95-6	15349-15357	auditory	_
95-7	15358-15364	evoked	_
95-8	15365-15374	potential	_
95-9	15375-15379	time	_
95-10	15380-15386	course	_
95-11	15387-15389	of	_
95-12	15390-15393	ERP	_
95-13	15394-15401	average	_
95-14	15402-15406	from	_
95-15	15407-15410	the	_
95-16	15411-15420	component	_
95-17	15421-15423	's	_
95-18	15424-15430	single	_
95-19	15431-15436	trial	_
95-20	15437-15443	epochs	_
95-21	15444-15445	,	_
95-22	15446-15449	and	_
95-23	15450-15453	1/f	_
95-24	15454-15459	power	_
95-25	15460-15468	spectrum	_
95-26	15469-15470	)	_
95-27	15471-15473	to	_
95-28	15474-15482	identify	_
95-29	15483-15494	ERP-related	_
95-30	15495-15506	independent	_
95-31	15507-15517	components	_
95-32	15518-15519	(	_
95-33	15520-15523	ICs	_
95-34	15524-15525	)	_
95-35	15526-15529	and	_
95-36	15530-15532	to	_
95-37	15533-15540	exclude	_
95-38	15541-15557	artifact-related	_
95-39	15558-15561	ICs	_
95-40	15562-15563	,	_
95-41	15564-15567	and	_
95-42	15568-15572	then	_
95-43	15573-15577	they	_
95-44	15578-15587	conferred	_
95-45	15588-15590	to	_
95-46	15591-15598	achieve	_
95-47	15599-15608	consensus	_
95-48	15609-15611	on	_
95-49	15612-15617	which	_
95-50	15618-15621	ICs	_
95-51	15622-15624	to	_
95-52	15625-15631	retain	_
95-53	15632-15633	.	_

Text=Data from 13 (5 HC, 8 SZ) subjects were dropped from further analysis because zero components were selected (i.e.
96-1	15634-15638	Data	_
96-2	15639-15643	from	_
96-3	15644-15646	13	_
96-4	15647-15648	(	_
96-5	15649-15650	5	_
96-6	15651-15653	HC	_
96-7	15654-15655	,	_
96-8	15656-15657	8	_
96-9	15658-15660	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
96-10	15661-15662	)	_
96-11	15663-15671	subjects	_
96-12	15672-15676	were	_
96-13	15677-15684	dropped	_
96-14	15685-15689	from	_
96-15	15690-15697	further	_
96-16	15698-15706	analysis	_
96-17	15707-15714	because	_
96-18	15715-15719	zero	_
96-19	15720-15730	components	_
96-20	15731-15735	were	_
96-21	15736-15744	selected	_
96-22	15745-15746	(	_
96-23	15747-15750	i.e	_
96-24	15751-15752	.	_

Text=none of the ICs satisfied the criteria used to identify EEG/ERP ICs).
97-1	15753-15757	none	_
97-2	15758-15760	of	_
97-3	15761-15764	the	_
97-4	15765-15768	ICs	_
97-5	15769-15778	satisfied	_
97-6	15779-15782	the	_
97-7	15783-15791	criteria	_
97-8	15792-15796	used	_
97-9	15797-15799	to	_
97-10	15800-15808	identify	_
97-11	15809-15816	EEG/ERP	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
97-12	15817-15820	ICs	_
97-13	15821-15822	)	_
97-14	15823-15824	.	_

Text=The mean framewise displacement in this group of 13 participants suggested significantly greater mean motion values (median = 0.1656) than the 53 participants included in the analysis (median = 0.0856) using a Wilcoxon rank sum test (Z = 3.466, W = 651, p = 0.0005).
98-1	15825-15828	The	_
98-2	15829-15833	mean	_
98-3	15834-15843	framewise	_
98-4	15844-15856	displacement	_
98-5	15857-15859	in	_
98-6	15860-15864	this	_
98-7	15865-15870	group	_
98-8	15871-15873	of	_
98-9	15874-15876	13	_
98-10	15877-15889	participants	_
98-11	15890-15899	suggested	_
98-12	15900-15913	significantly	_
98-13	15914-15921	greater	_
98-14	15922-15926	mean	_
98-15	15927-15933	motion	_
98-16	15934-15940	values	_
98-17	15941-15942	(	_
98-18	15943-15949	median	_
98-19	15950-15951	=	_
98-20	15952-15958	0.1656	_
98-21	15959-15960	)	_
98-22	15961-15965	than	_
98-23	15966-15969	the	_
98-24	15970-15972	53	_
98-25	15973-15985	participants	_
98-26	15986-15994	included	_
98-27	15995-15997	in	_
98-28	15998-16001	the	_
98-29	16002-16010	analysis	_
98-30	16011-16012	(	_
98-31	16013-16019	median	_
98-32	16020-16021	=	_
98-33	16022-16028	0.0856	_
98-34	16029-16030	)	_
98-35	16031-16036	using	_
98-36	16037-16038	a	_
98-37	16039-16047	Wilcoxon	_
98-38	16048-16052	rank	_
98-39	16053-16056	sum	_
98-40	16057-16061	test	_
98-41	16062-16063	(	_
98-42	16064-16065	Z	_
98-43	16066-16067	=	_
98-44	16068-16073	3.466	_
98-45	16074-16075	,	_
98-46	16076-16077	W	_
98-47	16078-16079	=	_
98-48	16080-16083	651	_
98-49	16084-16085	,	_
98-50	16086-16087	p	_
98-51	16088-16089	=	_
98-52	16090-16096	0.0005	_
98-53	16097-16098	)	_
98-54	16099-16100	.	_

Text=Retained IC single trial data were then back-projected and averaged to generate a separate cleaned ERP for each subject and channel.
99-1	16101-16109	Retained	_
99-2	16110-16112	IC	_
99-3	16113-16119	single	_
99-4	16120-16125	trial	_
99-5	16126-16130	data	_
99-6	16131-16135	were	_
99-7	16136-16140	then	_
99-8	16141-16155	back-projected	_
99-9	16156-16159	and	_
99-10	16160-16168	averaged	_
99-11	16169-16171	to	_
99-12	16172-16180	generate	_
99-13	16181-16182	a	_
99-14	16183-16191	separate	_
99-15	16192-16199	cleaned	_
99-16	16200-16203	ERP	_
99-17	16204-16207	for	_
99-18	16208-16212	each	_
99-19	16213-16220	subject	_
99-20	16221-16224	and	_
99-21	16225-16232	channel	_
99-22	16233-16234	.	_

Text=Resulting ERP waveforms were low-pass filtered at 30 Hz.
100-1	16235-16244	Resulting	_
100-2	16245-16248	ERP	_
100-3	16249-16258	waveforms	_
100-4	16259-16263	were	_
100-5	16264-16272	low-pass	_
100-6	16273-16281	filtered	_
100-7	16282-16284	at	_
100-8	16285-16287	30	_
100-9	16288-16290	Hz	_
100-10	16291-16292	.	_

Text=Integration of EEG and fMRI data We conducted a joint independent components analysis (jICA) using the Matlab-based Fusion ICA Toolbox or “ FIT ”.
101-1	16293-16304	Integration	_
101-2	16305-16307	of	_
101-3	16308-16311	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
101-4	16312-16315	and	_
101-5	16316-16320	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
101-6	16321-16325	data	_
101-7	16326-16328	We	_
101-8	16329-16338	conducted	_
101-9	16339-16340	a	_
101-10	16341-16346	joint	_
101-11	16347-16358	independent	_
101-12	16359-16369	components	_
101-13	16370-16378	analysis	_
101-14	16379-16380	(	_
101-15	16381-16385	jICA	_
101-16	16386-16387	)	_
101-17	16388-16393	using	_
101-18	16394-16397	the	_
101-19	16398-16410	Matlab-based	_
101-20	16411-16417	Fusion	_
101-21	16418-16421	ICA	_
101-22	16422-16429	Toolbox	_
101-23	16430-16432	or	_
101-24	16433-16434	“	_
101-25	16435-16438	FIT	_
101-26	16439-16440	”	_
101-27	16441-16442	.	_

Text=Joint ICA is a multi-modal data reduction technique that has been used to combine ERP and fMRI data collected simultaneously or in separate sessions.
102-1	16443-16448	Joint	_
102-2	16449-16452	ICA	_
102-3	16453-16455	is	_
102-4	16456-16457	a	_
102-5	16458-16469	multi-modal	_
102-6	16470-16474	data	_
102-7	16475-16484	reduction	_
102-8	16485-16494	technique	_
102-9	16495-16499	that	_
102-10	16500-16503	has	_
102-11	16504-16508	been	_
102-12	16509-16513	used	_
102-13	16514-16516	to	_
102-14	16517-16524	combine	_
102-15	16525-16528	ERP	_
102-16	16529-16532	and	_
102-17	16533-16537	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
102-18	16538-16542	data	_
102-19	16543-16552	collected	_
102-20	16553-16567	simultaneously	_
102-21	16568-16570	or	_
102-22	16571-16573	in	_
102-23	16574-16582	separate	_
102-24	16583-16591	sessions	_
102-25	16592-16593	.	_

Text=FIT uses each subject's ERP and fMRI data (i.e.
103-1	16594-16597	FIT	_
103-2	16598-16602	uses	_
103-3	16603-16607	each	_
103-4	16608-16615	subject	_
103-5	16616-16618	's	_
103-6	16619-16622	ERP	_
103-7	16623-16626	and	_
103-8	16627-16631	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
103-9	16632-16636	data	_
103-10	16637-16638	(	_
103-11	16639-16642	i.e	_
103-12	16643-16644	.	_

Text=ERP time courses and fMRI beta maps) concatenated side-by-side.
104-1	16645-16648	ERP	_
104-2	16649-16653	time	_
104-3	16654-16661	courses	_
104-4	16662-16665	and	_
104-5	16666-16670	fMRI	_
104-6	16671-16675	beta	_
104-7	16676-16680	maps	_
104-8	16681-16682	)	_
104-9	16683-16695	concatenated	_
104-10	16696-16708	side-by-side	_
104-11	16709-16710	.	_

Text=The ERP time course is re-sampled to a higher rate such that the number of ERP time samples and the number of fMRI spatial samples are equal.
105-1	16711-16714	The	_
105-2	16715-16718	ERP	_
105-3	16719-16723	time	_
105-4	16724-16730	course	_
105-5	16731-16733	is	_
105-6	16734-16744	re-sampled	_
105-7	16745-16747	to	_
105-8	16748-16749	a	_
105-9	16750-16756	higher	_
105-10	16757-16761	rate	_
105-11	16762-16766	such	_
105-12	16767-16771	that	_
105-13	16772-16775	the	_
105-14	16776-16782	number	_
105-15	16783-16785	of	_
105-16	16786-16789	ERP	_
105-17	16790-16794	time	_
105-18	16795-16802	samples	_
105-19	16803-16806	and	_
105-20	16807-16810	the	_
105-21	16811-16817	number	_
105-22	16818-16820	of	_
105-23	16821-16825	fMRI	_
105-24	16826-16833	spatial	_
105-25	16834-16841	samples	_
105-26	16842-16845	are	_
105-27	16846-16851	equal	_
105-28	16852-16853	.	_

Text=Sources associated with these modalities are assumed to co-vary the same way across groups and subjects (i.e.
106-1	16854-16861	Sources	_
106-2	16862-16872	associated	_
106-3	16873-16877	with	_
106-4	16878-16883	these	_
106-5	16884-16894	modalities	_
106-6	16895-16898	are	_
106-7	16899-16906	assumed	_
106-8	16907-16909	to	_
106-9	16910-16917	co-vary	_
106-10	16918-16921	the	_
106-11	16922-16926	same	_
106-12	16927-16930	way	_
106-13	16931-16937	across	_
106-14	16938-16944	groups	_
106-15	16945-16948	and	_
106-16	16949-16957	subjects	_
106-17	16958-16959	(	_
106-18	16960-16963	i.e	_
106-19	16964-16965	.	_

Text=equal linear covariation).
107-1	16966-16971	equal	_
107-2	16972-16978	linear	_
107-3	16979-16990	covariation	_
107-4	16991-16992	)	_
107-5	16993-16994	.	_

Text=Prior to calculating the jICA, the number of components in each imaging modality was estimated.
108-1	16995-17000	Prior	_
108-2	17001-17003	to	_
108-3	17004-17015	calculating	_
108-4	17016-17019	the	_
108-5	17020-17024	jICA	_
108-6	17025-17026	,	_
108-7	17027-17030	the	_
108-8	17031-17037	number	_
108-9	17038-17040	of	_
108-10	17041-17051	components	_
108-11	17052-17054	in	_
108-12	17055-17059	each	_
108-13	17060-17067	imaging	_
108-14	17068-17076	modality	_
108-15	17077-17080	was	_
108-16	17081-17090	estimated	_
108-17	17091-17092	.	_

Text=FIT estimated the number of fMRI components to be 5 based on the minimum description length.
109-1	17093-17096	FIT	_
109-2	17097-17106	estimated	_
109-3	17107-17110	the	_
109-4	17111-17117	number	_
109-5	17118-17120	of	_
109-6	17121-17125	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
109-7	17126-17136	components	_
109-8	17137-17139	to	_
109-9	17140-17142	be	_
109-10	17143-17144	5	_
109-11	17145-17150	based	_
109-12	17151-17153	on	_
109-13	17154-17157	the	_
109-14	17158-17165	minimum	_
109-15	17166-17177	description	_
109-16	17178-17184	length	_
109-17	17185-17186	.	_

Text=The parallel test approach was used on the ERP data, indicating that there were 3 components in that modality.
110-1	17187-17190	The	_
110-2	17191-17199	parallel	_
110-3	17200-17204	test	_
110-4	17205-17213	approach	_
110-5	17214-17217	was	_
110-6	17218-17222	used	_
110-7	17223-17225	on	_
110-8	17226-17229	the	_
110-9	17230-17233	ERP	_
110-10	17234-17238	data	_
110-11	17239-17240	,	_
110-12	17241-17251	indicating	_
110-13	17252-17256	that	_
110-14	17257-17262	there	_
110-15	17263-17267	were	_
110-16	17268-17269	3	_
110-17	17270-17280	components	_
110-18	17281-17283	in	_
110-19	17284-17288	that	_
110-20	17289-17297	modality	_
110-21	17298-17299	.	_

Text=We chose the larger of these two numbers (N = 5) in the jICA, and each of the 5 components estimated had fMRI and ERP loadings that represented different patterns of spatio-temporal covariance between the modalities.
111-1	17300-17302	We	_
111-2	17303-17308	chose	_
111-3	17309-17312	the	_
111-4	17313-17319	larger	_
111-5	17320-17322	of	_
111-6	17323-17328	these	_
111-7	17329-17332	two	_
111-8	17333-17340	numbers	_
111-9	17341-17342	(	_
111-10	17343-17344	N	_
111-11	17345-17346	=	_
111-12	17347-17348	5	_
111-13	17349-17350	)	_
111-14	17351-17353	in	_
111-15	17354-17357	the	_
111-16	17358-17362	jICA	_
111-17	17363-17364	,	_
111-18	17365-17368	and	_
111-19	17369-17373	each	_
111-20	17374-17376	of	_
111-21	17377-17380	the	_
111-22	17381-17382	5	_
111-23	17383-17393	components	_
111-24	17394-17403	estimated	_
111-25	17404-17407	had	_
111-26	17408-17412	fMRI	_
111-27	17413-17416	and	_
111-28	17417-17420	ERP	_
111-29	17421-17429	loadings	_
111-30	17430-17434	that	_
111-31	17435-17446	represented	_
111-32	17447-17456	different	_
111-33	17457-17465	patterns	_
111-34	17466-17468	of	_
111-35	17469-17484	spatio-temporal	_
111-36	17485-17495	covariance	_
111-37	17496-17503	between	_
111-38	17504-17507	the	_
111-39	17508-17518	modalities	_
111-40	17519-17520	.	_

Text=Each subject had coefficients or scores associated with these 5 components' loadings that could be used in statistical tests.
112-1	17521-17525	Each	_
112-2	17526-17533	subject	_
112-3	17534-17537	had	_
112-4	17538-17550	coefficients	_
112-5	17551-17553	or	_
112-6	17554-17560	scores	_
112-7	17561-17571	associated	_
112-8	17572-17576	with	_
112-9	17577-17582	these	_
112-10	17583-17584	5	_
112-11	17585-17595	components	_
112-12	17596-17597	'	_
112-13	17598-17606	loadings	_
112-14	17607-17611	that	_
112-15	17612-17617	could	_
112-16	17618-17620	be	_
112-17	17621-17625	used	_
112-18	17626-17628	in	_
112-19	17629-17640	statistical	_
112-20	17641-17646	tests	_
112-21	17647-17648	.	_

Text=However, we first checked the validity of each component with a method similar to that used by others.
113-1	17649-17656	However	_
113-2	17657-17658	,	_
113-3	17659-17661	we	_
113-4	17662-17667	first	_
113-5	17668-17675	checked	_
113-6	17676-17679	the	_
113-7	17680-17688	validity	_
113-8	17689-17691	of	_
113-9	17692-17696	each	_
113-10	17697-17706	component	_
113-11	17707-17711	with	_
113-12	17712-17713	a	_
113-13	17714-17720	method	_
113-14	17721-17728	similar	_
113-15	17729-17731	to	_
113-16	17732-17736	that	_
113-17	17737-17741	used	_
113-18	17742-17744	by	_
113-19	17745-17751	others	_
113-20	17752-17753	.	_

Text=Specifically, the grand average ERP time course was regressed on the IC time course, and a peak (i.e.
114-1	17754-17766	Specifically	_
114-2	17767-17768	,	_
114-3	17769-17772	the	_
114-4	17773-17778	grand	_
114-5	17779-17786	average	_
114-6	17787-17790	ERP	_
114-7	17791-17795	time	_
114-8	17796-17802	course	_
114-9	17803-17806	was	_
114-10	17807-17816	regressed	_
114-11	17817-17819	on	_
114-12	17820-17823	the	_
114-13	17824-17826	IC	_
114-14	17827-17831	time	_
114-15	17832-17838	course	_
114-16	17839-17840	,	_
114-17	17841-17844	and	_
114-18	17845-17846	a	_
114-19	17847-17851	peak	_
114-20	17852-17853	(	_
114-21	17854-17857	i.e	_
114-22	17858-17859	.	_

Text=maximum absolute value) was picked from the fitted values of that regression model.
115-1	17860-17867	maximum	_
115-2	17868-17876	absolute	_
115-3	17877-17882	value	_
115-4	17883-17884	)	_
115-5	17885-17888	was	_
115-6	17889-17895	picked	_
115-7	17896-17900	from	_
115-8	17901-17904	the	_
115-9	17905-17911	fitted	_
115-10	17912-17918	values	_
115-11	17919-17921	of	_
115-12	17922-17926	that	_
115-13	17927-17937	regression	_
115-14	17938-17943	model	_
115-15	17944-17945	.	_

Text=There were only two components with monophasic waveforms and peaks that exceeded one standard deviation (0.6724 μV) of the grand average ERP.
116-1	17946-17951	There	_
116-2	17952-17956	were	_
116-3	17957-17961	only	_
116-4	17962-17965	two	_
116-5	17966-17976	components	_
116-6	17977-17981	with	_
116-7	17982-17992	monophasic	_
116-8	17993-18002	waveforms	_
116-9	18003-18006	and	_
116-10	18007-18012	peaks	_
116-11	18013-18017	that	_
116-12	18018-18026	exceeded	_
116-13	18027-18030	one	_
116-14	18031-18039	standard	_
116-15	18040-18049	deviation	_
116-16	18050-18051	(	_
116-17	18052-18058	0.6724	_
116-18	18059-18061	μV	_
116-19	18062-18063	)	_
116-20	18064-18066	of	_
116-21	18067-18070	the	_
116-22	18071-18076	grand	_
116-23	18077-18084	average	_
116-24	18085-18088	ERP	_
116-25	18089-18090	.	_

Text=These two components captured the N100 and P200 peaks (Fig.
117-1	18091-18096	These	_
117-2	18097-18100	two	_
117-3	18101-18111	components	_
117-4	18112-18120	captured	_
117-5	18121-18124	the	_
117-6	18125-18129	N100	_
117-7	18130-18133	and	_
117-8	18134-18138	P200	_
117-9	18139-18144	peaks	_
117-10	18145-18146	(	_
117-11	18147-18150	Fig	_
117-12	18151-18152	.	_

Text=1, Fig.
118-1	18153-18154	1	_
118-2	18155-18156	,	_
118-3	18157-18160	Fig	_
118-4	18161-18162	.	_

Text=2), and are referred to as the “ N100 ” and “ P200 ” linked components to distinguish them from the N100 and P200 ERP components.
119-1	18163-18164	2	_
119-2	18165-18166	)	_
119-3	18167-18168	,	_
119-4	18169-18172	and	_
119-5	18173-18176	are	_
119-6	18177-18185	referred	_
119-7	18186-18188	to	_
119-8	18189-18191	as	_
119-9	18192-18195	the	_
119-10	18196-18197	“	_
119-11	18198-18202	N100	_
119-12	18203-18204	”	_
119-13	18205-18208	and	_
119-14	18209-18210	“	_
119-15	18211-18215	P200	_
119-16	18216-18217	”	_
119-17	18218-18224	linked	_
119-18	18225-18235	components	_
119-19	18236-18238	to	_
119-20	18239-18250	distinguish	_
119-21	18251-18255	them	_
119-22	18256-18260	from	_
119-23	18261-18264	the	_
119-24	18265-18269	N100	_
119-25	18270-18273	and	_
119-26	18274-18278	P200	_
119-27	18279-18282	ERP	_
119-28	18283-18293	components	_
119-29	18294-18295	.	_

Text=Individual subject joint component scores for these linked components were retained for subsequent analyses.
120-1	18296-18306	Individual	_
120-2	18307-18314	subject	_
120-3	18315-18320	joint	_
120-4	18321-18330	component	_
120-5	18331-18337	scores	_
120-6	18338-18341	for	_
120-7	18342-18347	these	_
120-8	18348-18354	linked	_
120-9	18355-18365	components	_
120-10	18366-18370	were	_
120-11	18371-18379	retained	_
120-12	18380-18383	for	_
120-13	18384-18394	subsequent	_
120-14	18395-18403	analyses	_
120-15	18404-18405	.	_

Text=These scores were compared between groups using independent samples t-tests.
121-1	18406-18411	These	_
121-2	18412-18418	scores	_
121-3	18419-18423	were	_
121-4	18424-18432	compared	_
121-5	18433-18440	between	_
121-6	18441-18447	groups	_
121-7	18448-18453	using	_
121-8	18454-18465	independent	_
121-9	18466-18473	samples	_
121-10	18474-18481	t-tests	_
121-11	18482-18483	.	_

Text=Relating clinical data to jICA data To assess the relationship between symptoms and neurophysiological data, we correlated the “ N100 ” and “ P200 ” joint independent component scores (JICs) to the 9 global ratings from SANS and SAPS, listed in Table 1.
122-1	18484-18492	Relating	_
122-2	18493-18501	clinical	_
122-3	18502-18506	data	_
122-4	18507-18509	to	_
122-5	18510-18514	jICA	_
122-6	18515-18519	data	_
122-7	18520-18522	To	_
122-8	18523-18529	assess	_
122-9	18530-18533	the	_
122-10	18534-18546	relationship	_
122-11	18547-18554	between	_
122-12	18555-18563	symptoms	_
122-13	18564-18567	and	_
122-14	18568-18586	neurophysiological	_
122-15	18587-18591	data	_
122-16	18592-18593	,	_
122-17	18594-18596	we	_
122-18	18597-18607	correlated	_
122-19	18608-18611	the	_
122-20	18612-18613	“	_
122-21	18614-18618	N100	_
122-22	18619-18620	”	_
122-23	18621-18624	and	_
122-24	18625-18626	“	_
122-25	18627-18631	P200	_
122-26	18632-18633	”	_
122-27	18634-18639	joint	_
122-28	18640-18651	independent	_
122-29	18652-18661	component	_
122-30	18662-18668	scores	_
122-31	18669-18670	(	_
122-32	18671-18675	JICs	_
122-33	18676-18677	)	_
122-34	18678-18680	to	_
122-35	18681-18684	the	_
122-36	18685-18686	9	_
122-37	18687-18693	global	_
122-38	18694-18701	ratings	_
122-39	18702-18706	from	_
122-40	18707-18711	SANS	_
122-41	18712-18715	and	_
122-42	18716-18720	SAPS	_
122-43	18721-18722	,	_
122-44	18723-18729	listed	_
122-45	18730-18732	in	_
122-46	18733-18738	Table	_
122-47	18739-18740	1	_
122-48	18741-18742	.	_

Text=The significance level for each component was Bonferroni corrected to 0.05/9 = 0.006.
123-1	18743-18746	The	_
123-2	18747-18759	significance	_
123-3	18760-18765	level	_
123-4	18766-18769	for	_
123-5	18770-18774	each	_
123-6	18775-18784	component	_
123-7	18785-18788	was	_
123-8	18789-18799	Bonferroni	_
123-9	18800-18809	corrected	_
123-10	18810-18812	to	_
123-11	18813-18819	0.05/9	_
123-12	18820-18821	=	_
123-13	18822-18827	0.006	_
123-14	18828-18829	.	_

